Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Otorhinolaryngology

  Free Subscription


Articles published in Head Neck

Retrieve available abstracts of 685 articles:
HTML format



Single Articles


    July 2021
  1. STOKES WA, Molina E, McDermott JD, Morgan RL, et al
    Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26809.
    PubMed     Abstract available


  2. SCHLIJPER R, Bos S, Hamilton SN, Tran E, et al
    Ninety-day mortality after radiotherapy for head and neck cancer: A population-based comparison between rural and urban patients.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26819.
    PubMed     Abstract available


  3. KIM MJ, Back K, Choe JH, Kim JH, et al
    Feasibility of lateral sentinel lymph node biopsy in medullary thyroid cancer: A surrogate tool for determining prophylactic lateral neck dissection-A pilot study.
    Head Neck. 2021 Jul 20. doi: 10.1002/hed.26808.
    PubMed     Abstract available


  4. DIAO K, Nguyen TP, Moreno AC, Reddy JP, et al
    Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: A large, single-institution, modern cohort study.
    Head Neck. 2021 Jul 16. doi: 10.1002/hed.26820.
    PubMed     Abstract available


  5. THANKAPPAN K, Subramanian S, Balasubramanian D, Kuriakose MA, et al
    Cost-effectiveness of oral cancer screening approaches by visual examination: A systematic review.
    Head Neck. 2021 Jul 14. doi: 10.1002/hed.26816.
    PubMed     Abstract available


  6. DING Z, Li Y, Pan X, Xuan M, et al
    Sentinel lymph node biopsy versus elective neck dissection in squamous cell carcinoma of the oral cavity with a clinically N0 neck: A systematic review and meta-analysis of prospective studies.
    Head Neck. 2021 Jul 10. doi: 10.1002/hed.26803.
    PubMed     Abstract available


  7. SHIGA K, Nibu KI, Fujimoto Y, Asakage T, et al
    Sites of invasion of cancer of the external auditory canal predicting oncologic outcomes.
    Head Neck. 2021 Jul 9. doi: 10.1002/hed.26800.
    PubMed     Abstract available


  8. REID P, Staudacher AH, Marcu LG, Olver I, et al
    Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26802.
    PubMed     Abstract available


  9. BADDOUR K, Fadel M, Zhao M, Corcoran M, et al
    The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26801.
    PubMed     Abstract available


  10. CHILLAKURU Y, Benito DA, Strum D, Mehta V, et al
    Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2259-2273.
    PubMed     Abstract available


  11. PFISTER NT, Beitler JJ, Stokes WA
    Contralateral nodal spread in human papillomavirus-associated oropharyngeal cancer: Can more details help guide contralateral neck coverage?
    Head Neck. 2021;43:2253.
    PubMed    


  12. HUSAIN S, Lohia S, Petkov V, Blackwell T, et al
    Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.
    Head Neck. 2021;43:2110-2123.
    PubMed     Abstract available


  13. CHEN L, Lin G, Qian J, Chen Z, et al
    A dynamic prognostic nomogram to predict the benefit from surgical treatment modality for patients with laryngeal squamous cell carcinoma.
    Head Neck. 2021;43:2148-2158.
    PubMed     Abstract available


  14. TOMBLINSON CM, Fletcher GP, Hu LS, Mi L, et al
    Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer.
    Head Neck. 2021;43:2185-2192.
    PubMed     Abstract available


  15. SAIYED FK, Guo T, Johnson F, Myers JN, et al
    Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2101-2109.
    PubMed     Abstract available


  16. CHARTERS E, Wu R, Milross C, Bogaardt H, et al
    Swallowing and communication outcomes following primary transoral robotic surgery.
    Head Neck. 2021;43:2013-2023.
    PubMed     Abstract available


  17. LASKAR SG, Pai P, Sinha S, Budrukkar A, et al
    Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute.
    Head Neck. 2021;43:2045-2057.
    PubMed     Abstract available


    June 2021
  18. GAO J, Tseng CC, Barinsky GL, Povolotskiy R, et al
    Exploratory analysis on the association of mental health disorders with in-hospital postoperative complications and mortality in head and neck cancer surgery.
    Head Neck. 2021 Jun 28. doi: 10.1002/hed.26791.
    PubMed     Abstract available


  19. BURBURE N, Handorf E, Ridge JA, Bauman J, et al
    Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.
    Head Neck. 2021 Jun 24. doi: 10.1002/hed.26793.
    PubMed     Abstract available


  20. FATEHI KS, Malik A
    Elective neck dissection and its extent in salivary gland cancers: A dilemma.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26777.
    PubMed    


  21. WESTERGAARD-NIELSEN M, Godballe C, Eriksen JG, Larsen SR, et al
    Reply to Letter to the Editor regarding "Elective neck dissection and its extent in Salivary gland cancers: A Dilemma".
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26778.
    PubMed    


  22. RICH BJ, Schumacher LD, Sargi ZB, Masforroll M, et al
    Opioid use patterns in patients with head and neck cancer receiving radiation therapy: A single-institution retrospective analysis characterizing patients who did not require opioid therapy.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26785.
    PubMed     Abstract available


  23. WEIZMAN B, Golan N, Ronen O
    Effect of socioeconomic status on survival in patients with head and neck cancer.
    Head Neck. 2021 Jun 16. doi: 10.1002/hed.26788.
    PubMed     Abstract available


  24. BERGAMINI C, Ferris RL, Xie J, Mariani G, et al
    Bleeding complications in patients with squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Jun 12. doi: 10.1002/hed.26772.
    PubMed     Abstract available


  25. CAVALHEIRO BG, de Matos LL, Leite AKN, Kulcsar MAV, et al
    Survival in differentiated thyroid carcinoma: A comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system.
    Head Neck. 2021 Jun 1. doi: 10.1002/hed.26773.
    PubMed     Abstract available


  26. SABIQ F, Huang K, Patel A, Banerjee R, et al
    Novel imaging classification system of nodal disease in human papillomavirus-mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes.
    Head Neck. 2021;43:1854-1863.
    PubMed     Abstract available


  27. SAMPLE RA, Wood CB, Mazul AL, Barrett TF, et al
    Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone.
    Head Neck. 2021;43:1759-1768.
    PubMed     Abstract available


  28. YAVUZ H, Vural O
    Tracheoesophageal puncture closure with annular mucosal flap.
    Head Neck. 2021;43:1705-1710.
    PubMed     Abstract available


    May 2021
  29. FAGAN JJ, Otiti J, Onakoya PA, Diom E, et al
    AfHNS fellowship: A model to improve access to head and neck cancer care in Africa and developing countries.
    Head Neck. 2021 May 29. doi: 10.1002/hed.26770.
    PubMed     Abstract available


  30. YANG S, Yuan ZJ, Zhu YH, Chen X, et al
    lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p.
    Head Neck. 2021 May 25. doi: 10.1002/hed.26742.
    PubMed     Abstract available


  31. CIVANTOS AM, Prasad A, Carey RM, Bur AM, et al
    Palliative care in metastatic head and neck cancer.
    Head Neck. 2021 May 21. doi: 10.1002/hed.26761.
    PubMed     Abstract available


  32. GOSHTASBI K, Abiri A, Lehrich BM, Haidar YM, et al
    The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26739.
    PubMed     Abstract available


  33. PANG J, Faraji F, Risa E, Mell LK, et al
    High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26736.
    PubMed     Abstract available


  34. HOESSEINI A, van Leeuwen N, Offerman MPJ, Zhang J, et al
    Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.
    Head Neck. 2021 May 7. doi: 10.1002/hed.26716.
    PubMed     Abstract available


  35. RIJO-CEDENO J, Mucientes J, Seijas Marcos S, Romero J, et al
    Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26725.
    PubMed     Abstract available


  36. VERMAIRE JA, Terhaard CHJ, Verdonck-de Leeuw IM, Raaijmakers CPJ, et al
    Reliability of the 100 mL water swallow test in patients with head and neck cancer and healthy subjects.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26723.
    PubMed     Abstract available


  37. LIAO W, He J, Gou Q, Duan B, et al
    Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26706.
    PubMed     Abstract available


  38. CHANG JW, Lee S, Lee JM, Moon IS, et al
    Occult parotid involvement in early-stage squamous cell carcinoma of the external auditory canal.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26729.
    PubMed     Abstract available


  39. OTTENSTEIN L, Cornett H, Switchenko JM, Nathan M, et al
    Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
    Head Neck. 2021;43:1629-1640.
    PubMed     Abstract available


  40. LIM Y, Tang KD, Karpe AV, Beale DJ, et al
    Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer.
    Head Neck. 2021;43:1521-1534.
    PubMed     Abstract available


  41. YOUNG A, Bigcas JL, Yang A, Reeve N, et al
    Transoral robotic submandibular gland transposition to reconstruct radical tonsillar resection defects.
    Head Neck. 2021;43:1695-1698.
    PubMed     Abstract available


  42. SMITH AW, Gallitto M, Lehrer EJ, Wasserman I, et al
    Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.
    Head Neck. 2021;43:1409-1414.
    PubMed     Abstract available


  43. MOLTENI G, Gazzini L, Sacchetto A, Nocini R, et al
    Role of the temporoparietal fascia free flap in salvage total laryngectomy.
    Head Neck. 2021;43:1692-1694.
    PubMed     Abstract available


  44. LIU HY, Daniels CP, Trada Y, Bernard A, et al
    The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2021;43:1440-1450.
    PubMed     Abstract available


  45. NOCON CC, Kuchta K, Bhayani MK
    Prognostic value of lymph node ratio versus American Joint Committee on Cancer N classification for surgically resected human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:1476-1486.
    PubMed     Abstract available


    April 2021
  46. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 Apr 27. doi: 10.1002/hed.26726.
    PubMed     Abstract available


  47. HIGHLAND J, Aylward A, Do O, Monroe M, et al
    Trust in physicians among patients with head and neck cancer before and after treatment.
    Head Neck. 2021 Apr 26. doi: 10.1002/hed.26721.
    PubMed     Abstract available


  48. SEKI-SODA M, Sano T, Ogawa M, Yokoo S, et al
    CD15(+) tumor infiltrating granulocytic cells can predict recurrence and their depletion is accompanied by good responses to S-1 with oral cancer.
    Head Neck. 2021 Apr 24. doi: 10.1002/hed.26712.
    PubMed     Abstract available


  49. NUYTS S, Bollen H, Eisbruch A, Corry J, et al
    Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Apr 19. doi: 10.1002/hed.26713.
    PubMed     Abstract available


  50. MESSING BP, Ward EC, Lazarus C, Ryniak K, et al
    Longitudinal comparisons of a whole-mouth taste test to clinician-rated and patient-reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake.
    Head Neck. 2021 Apr 15. doi: 10.1002/hed.26690.
    PubMed     Abstract available


  51. WANG SM, Yin SC, Su XZ, Xu Q, et al
    Magnitude of radial forearm free flaps and factors associated with loss of volume in oral cancer reconstructive surgery: A prospective study.
    Head Neck. 2021 Apr 13. doi: 10.1002/hed.26704.
    PubMed     Abstract available


  52. WIBONELE BK, Smith BD, Altonji S, Kaplan S, et al
    Head and neck cancer research collaborations between the United States and low- and middle-income countries: A 10-year publication analysis.
    Head Neck. 2021 Apr 5. doi: 10.1002/hed.26703.
    PubMed     Abstract available


  53. YANG N, Mercier E, Guertin L, Bissada E, et al
    Development, translation, and preliminary validation of the neck dissection assessment tool.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26696.
    PubMed     Abstract available


  54. SMITS HJG, Assili S, Kauw F, Philippens MEP, et al
    Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic and meta-analysis.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26698.
    PubMed     Abstract available


  55. MILINIS K, Gaskell P, Lau A, Lancaster J, et al
    Early versus late oral feeding following total (pharyngo)laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:1359-1368.
    PubMed     Abstract available


  56. XING MH, Mundi N, Govindan A, Khorsandi A, et al
    Unusual location of a second branchial cleft cyst presenting in the suprasternal notch.
    Head Neck. 2021;43:E27-E29.
    PubMed     Abstract available


  57. ATALLAH I, Castellanos PF
    Transoral closure of the supraglottic larynx for intractable aspiration.
    Head Neck. 2021;43:1370-1375.
    PubMed     Abstract available


  58. SINHA S, Agarwal JP, Mahajan A, Chaturvedi P, et al
    Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study.
    Head Neck. 2021;43:1289-1299.
    PubMed     Abstract available


  59. MCKENZIE RM, Parhar HS, Ng TL, Prisman E, et al
    Muscle invasion in oropharyngeal carcinoma undergoing transoral robotic surgery.
    Head Neck. 2021;43:1194-1201.
    PubMed     Abstract available


  60. MATTIOLI F, Fernandez IJ, Bassano E, Luppi MP, et al
    Surgical rehabilitation of swallowing with polydimethylsiloxane injections after open partial horizontal laryngectomy: Long-term functional results and quality of life.
    Head Neck. 2021;43:1161-1173.
    PubMed     Abstract available


  61. CAREY RM, Shimunov D, Weinstein GS, Cannady SB, et al
    Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy.
    Head Neck. 2021;43:1128-1141.
    PubMed     Abstract available


  62. SUN M, Wang K, Qu Y, Zhang J, et al
    Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
    Head Neck. 2021;43:1097-1104.
    PubMed     Abstract available


  63. KUMAR A, Laskar SG, Thiagarajan S
    Is Transoral Robotic Surgery (TORS) for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1376-1377.
    PubMed    


  64. BATES JE, Amdur RJ
    In reply to Kumar et al, Is TORS for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1378-1379.
    PubMed    


    March 2021
  65. GUAN H, He Y, Su Y, Wei Z, et al
    Assessment of different induction chemotherapy regimens in locally advanced nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2021 Mar 31. doi: 10.1002/hed.26699.
    PubMed     Abstract available


  66. LI W, Lu H, Wang H, Hu L, et al
    Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26687.
    PubMed     Abstract available


  67. NG WT, Tsang RKY, Beitler JJ, de Bree R, et al
    Contemporary management of the neck in nasopharyngeal carcinoma.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26685.
    PubMed     Abstract available


  68. EBERSOLE B, McCarroll L, Ridge JA, Liu JC, et al
    Identification and management of late dysfunction in survivors of head and neck cancer: Implementation and outcomes of an interdisciplinary quality of life (IQOL) clinic.
    Head Neck. 2021 Mar 21. doi: 10.1002/hed.26681.
    PubMed     Abstract available


  69. STADLER TM, Morand GB, Rupp NJ, Hullner MW, et al
    FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
    Head Neck. 2021 Mar 17. doi: 10.1002/hed.26668.
    PubMed     Abstract available


  70. SHAH R, Gosavi V, Mahajan A, Sonawane S, et al
    Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26677.
    PubMed     Abstract available


  71. PATEL U, Mittal N, Rane SU, Patil A, et al
    Correlation of transcriptionally active human papillomavirus status with the clinical and molecular profiles of head and neck squamous cell carcinomas.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26676.
    PubMed     Abstract available


  72. SAKA-HERRAN C, Jane-Salas E, Estrugo-Devesa A, Lopez-Lopez J, et al
    Head and neck cancer and non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis.
    Head Neck. 2021 Mar 8. doi: 10.1002/hed.26663.
    PubMed     Abstract available


  73. SANSA A, Venegas MDP, Valero C, Pardo L, et al
    The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.
    Head Neck. 2021 Mar 6. doi: 10.1002/hed.26673.
    PubMed     Abstract available


  74. FASSAS S, Cummings E, Sykes KJ, Bur AM, et al
    Telemedicine for head and neck cancer surveillance in the COVID-19 era: Promise and pitfalls.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26659.
    PubMed     Abstract available


  75. WARREN EAK, Anil J, Castro PD, Kemnade J, et al
    Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26662.
    PubMed     Abstract available


  76. BUGTER O, van Iwaarden DLP, van Leeuwen N, Nieboer D, et al
    A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study.
    Head Neck. 2021 Mar 3. doi: 10.1002/hed.26666.
    PubMed     Abstract available


  77. KIONG KL, Diaz EM, Gross ND, Diaz EM Jr, et al
    The impact of COVID-19 on head and neck cancer diagnosis and disease extent.
    Head Neck. 2021 Mar 2. doi: 10.1002/hed.26665.
    PubMed     Abstract available


  78. DICKSTEIN DR, Egerman M, Monrose E, Varma A, et al
    Treatment tolerability and outcomes in elderly patients with head and neck cancer.
    Head Neck. 2021;43:858-873.
    PubMed     Abstract available


  79. RITTER A, Hod R, Reuven Y, Shpitzer T, et al
    Role of intraoperative recurrent laryngeal nerve monitoring for pediatric thyroid surgery: Comparative analysis.
    Head Neck. 2021;43:849-857.
    PubMed     Abstract available


    February 2021
  80. LI M, Zhang B, Chen Q, Zhang L, et al
    Concurrent chemoradiotherapy with additional chemotherapy for nasopharyngeal carcinoma: A pooled analysis of propensity score-matching studies.
    Head Neck. 2021 Feb 28. doi: 10.1002/hed.26664.
    PubMed     Abstract available


  81. STEPAN KO, Mazul AL, Skillington SA, Paniello RC, et al
    The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Head Neck. 2021 Feb 23. doi: 10.1002/hed.26639.
    PubMed     Abstract available


  82. VAN DER LANS RJL, Engel MSD, Rijken JA, Hensen EF, et al
    Neuroendocrine neoplasms of the middle ear: Unpredictable tumor behavior and tendency for recurrence.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26658.
    PubMed     Abstract available


  83. YANG K, Li M, Zhu J, Zeng L, et al
    Nomograms for predicting survival outcomes in intensity-modulated radiotherapy era of nasopharyngeal carcinoma: A study based on Epstein-Barr virus DNA biological responses.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26654.
    PubMed     Abstract available


  84. RAMSEY T, Lee B, Curran K, Desai V, et al
    Associations of insurance, urbanity, and comorbidity with types of palliative care received by patients with head and neck cancer.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26648.
    PubMed     Abstract available


  85. RANGABASHYAM M, Koh SQ, Sultana R, Tan NC, et al
    Factors associated with returning to work in head and neck cancer survivors in Singapore: A preliminary exploratory mixed-methods approach study.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26644.
    PubMed     Abstract available


  86. FUNG SYH, Chan KCA, Wong EWY, Ng CWK, et al
    Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26647.
    PubMed     Abstract available


  87. SABOUR S, Ghajari H
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26645.
    PubMed    


  88. ELSHARAWI R, Antonucci E, Sukari A, Cramer JD, et al
    Quality metrics for head and neck cancer treated with definitive radiotherapy and/or chemotherapy.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26640.
    PubMed     Abstract available


  89. GUO J, Gui R
    Reply: Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues (HED-20-22881).
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26652.
    PubMed    


  90. USHINSKY A, Guevara CJ, Kim SK
    Intranodal lymphangiography with thoracic duct embolization for the treatment of chyle leaks after head and neck cancer surgery.
    Head Neck. 2021 Feb 15. doi: 10.1002/hed.26646.
    PubMed     Abstract available


  91. GRECO E, Ringash J, Tomlinson G, Huang SH, et al
    Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy.
    Head Neck. 2021 Feb 13. doi: 10.1002/hed.26638.
    PubMed     Abstract available


  92. BURGIN SJM, Spector ME, Pearson AT, Bellile E, et al
    Long-term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index.
    Head Neck. 2021 Feb 12. doi: 10.1002/hed.26636.
    PubMed     Abstract available


  93. POON DMC, Kam MKM, Johnson D, Mo F, et al
    Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
    Head Neck. 2021 Feb 11. doi: 10.1002/hed.26634.
    PubMed     Abstract available


  94. ANG MK, Montoya JE, Tharavichitkul E, Lim C, et al
    A phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 5. doi: 10.1002/hed.26635.
    PubMed     Abstract available


  95. XIE G, Zhu A, Gu X
    Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 3. doi: 10.1002/hed.26633.
    PubMed     Abstract available


  96. ALVES LDB, Menezes ACS, Pereira DL, Santos MTC, et al
    Benefits of intraoral stents in patients with head and neck cancer undergoing radiotherapy: Systematic review.
    Head Neck. 2021 Feb 1. doi: 10.1002/hed.26620.
    PubMed     Abstract available


  97. HOLCOMB AJ, Richmon JD
    Transoral robotic salvage oropharyngectomy with submental artery island flap reconstruction.
    Head Neck. 2021;43:E13-E19.
    PubMed     Abstract available


  98. LAO WP, Lagabon KJ, Arom GA, Walker PC, et al
    Combined endoscopic and transoral resection of a high-staged juvenile nasopharyngeal angiofibroma: A pictorial essay.
    Head Neck. 2021;43:719-724.
    PubMed     Abstract available


  99. LE FLEM M, Santini L, Boulze C, Alshukry A, et al
    Reply to the Letter to the Editor regarding "Early oral hydration protects against pharyngocutaneous fistula after total laryngectomy or total pharyngolaryngectomy".
    Head Neck. 2021;43:718.
    PubMed    


  100. BINZ GHA, Soyka MB, Holzmann D, Meerwein CM, et al
    Need for long-term follow-up in sinonasal inverted papilloma: A Single-institution experience.
    Head Neck. 2021;43:630-638.
    PubMed     Abstract available


  101. EDAFE O
    Impact of early oral hydration on pharyngocutaneous fistula following total laryngectomy.
    Head Neck. 2021;43:716-717.
    PubMed    


  102. HUANG SH, de Almeida JR, Watson E, Glogauer M, et al
    Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma.
    Head Neck. 2021;43:456-466.
    PubMed     Abstract available


  103. SU WW, Lee YH, Yen AM, Chen SL, et al
    Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening program.
    Head Neck. 2021;43:473-484.
    PubMed     Abstract available


  104. BOS P, van den Brekel MWM, Gouw ZAR, Al-Mamgani A, et al
    Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer.
    Head Neck. 2021;43:485-495.
    PubMed     Abstract available


  105. HUANG TY, Lin YC, Tseng HY, Kim HY, et al
    Full percutaneous intraoperative neuromonitoring technique in remote thyroid surgery: Porcine model feasibility study.
    Head Neck. 2021;43:505-513.
    PubMed     Abstract available


    January 2021
  106. GISSI DB, Morandi L, Colella G, De Luca R, et al
    Clinical validation of 13-gene DNA methylation analysis in oral brushing samples for detection of oral carcinoma: An Italian multicenter study.
    Head Neck. 2021 Jan 28. doi: 10.1002/hed.26624.
    PubMed     Abstract available


  107. HOPKINS-ROSSABI T, Armeson KE, Zecker SG, Martin-Harris B, et al
    Respiratory-swallow coordination and swallowing impairment in head and neck cancer.
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26609.
    PubMed     Abstract available


  108. IQBAL MS, Kelly C, Kovarik J, McQueen A, et al
    Rapid recurrence in postoperative head and neck cancer: Underappreciated or overcalled problem?
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26615.
    PubMed    


  109. POLCE S, Gogineni E, Antone J, Ghaly M, et al
    Dental radiation dosimetric maps from intensity-modulated radiation therapy planning for head and neck cancers.
    Head Neck. 2021 Jan 15. doi: 10.1002/hed.26611.
    PubMed     Abstract available


  110. WEI ZG, Hu XL, He Y, Guan H, et al
    Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.
    Head Neck. 2021 Jan 9. doi: 10.1002/hed.26608.
    PubMed     Abstract available


  111. MAYS AC, Yarlagadda B, Achim V, Jackson R, et al
    Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26601.
    PubMed     Abstract available


  112. INGARFIELD K, McMahon AD, Hurley K, Toms S, et al
    Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26589.
    PubMed     Abstract available


  113. BROEMER L, Friedrich M, Wichmann G, Muller J, et al
    Exploratory study of functional and psychological factors associated with employment status in patients with head and neck cancer.
    Head Neck. 2021 Jan 1. doi: 10.1002/hed.26595.
    PubMed     Abstract available


  114. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Bipedicled submental musculofascial "hammock" flap for salvage laryngectomy closure reinforcement.
    Head Neck. 2021;43:198-202.
    PubMed     Abstract available


  115. SHARBEL DD, Abkemeier M, Sullivan J, Zimmerman Z, et al
    Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:334-344.
    PubMed     Abstract available


  116. MOORE EJ, Van Abel KM, Routman DM, Lohse CM, et al
    Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
    Head Neck. 2021;43:229-237.
    PubMed     Abstract available


  117. CLARK CM, Newark AC, Fokar A, Maxwell JH, et al
    Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwide Veterans Affairs database study.
    Head Neck. 2021;43:247-254.
    PubMed     Abstract available


  118. FUNG AS, Afzal AR, Banerjee R, Debenham B, et al
    A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma.
    Head Neck. 2021;43:153-163.
    PubMed     Abstract available


  119. PANUGANTI BA, Stuart E, Weissbrod P
    Changes in treatment trends in the early glottic cancer population after the Affordable Care Act.
    Head Neck. 2021;43:137-144.
    PubMed     Abstract available


  120. CHWEYA CM, Low CM, Van Gompel JJ, Van Abel KM, et al
    Population-based analysis on the effect of nodal and distant metastases in sinonasal adenocarcinoma.
    Head Neck. 2021;43:128-136.
    PubMed     Abstract available


  121. ZEVALLOS JP, Kramer JR, Sandulache VC, Massa ST, et al
    National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System.
    Head Neck. 2021;43:108-115.
    PubMed     Abstract available


  122. THONG G, Brophy C, Sheahan P
    Use of intraoperative neural monitoring for prognostication of recovery of vocal mobility and reduction of permanent vocal paralysis after thyroidectomy.
    Head Neck. 2021;43:7-14.
    PubMed     Abstract available


    December 2020
  123. PANDIT PN, Patil RA, Palwe VS, Tambade SH, et al
    Patterns of blood pressure changes in patients with head and neck cancer receiving radiotherapy or chemo-radiotherapy at a tertiary cancer centre.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26590.
    PubMed     Abstract available


  124. FANG R, Peng L, Chen L, Liao J, et al
    The survival benefit of lymph node dissection in resected T1-2, cN0 supraglottic cancer: A population-based propensity score matching analysis.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26596.
    PubMed     Abstract available


  125. STARR N, Oyler DR, Schadler A, Aouad RK, et al
    Chronic opioid use after laryngeal cancer treatment.
    Head Neck. 2020 Dec 28. doi: 10.1002/hed.26591.
    PubMed     Abstract available


  126. RAO VUS, Subash A, R Bhargavi V, Sinha P, et al
    Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomas.
    Head Neck. 2020 Dec 24. doi: 10.1002/hed.26585.
    PubMed     Abstract available


  127. KISHIKAWA T, Suzuki M, Takemoto N, Fukusumi T, et al
    Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2020 Dec 23. doi: 10.1002/hed.26583.
    PubMed     Abstract available


  128. GARCIA-ANAYA MJ, Ordonez R, Toledo MD, Correa RC, et al
    Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy.
    Head Neck. 2020 Dec 15. doi: 10.1002/hed.26555.
    PubMed     Abstract available


  129. ANDERSON EM, Luu M, Balzer BL, Scher KS, et al
    Variations in the association of grade with survival across the head and neck cancer landscape.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26566.
    PubMed     Abstract available


  130. CHEN G, Jiang H, Jiang D, Wu Q, et al
    Pretreatment serum vitamin level predicts severity of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26576.
    PubMed     Abstract available


  131. SANDLER ML, Xing MH, Levy JC, Chai RL, et al
    Metastatic thyroid carcinoma to the parapharyngeal and retropharyngeal spaces: Systematic review with seven newly reported cases describing an uncommon presentation of a common disease.
    Head Neck. 2020 Dec 9. doi: 10.1002/hed.26572.
    PubMed     Abstract available


  132. CARNABY GD, Chhabria K
    Preliminary development and validation of a measure of fear of swallowing and swallowing-related movement injury in head and neck cancer: Swallowing Kinesiophobia Scale.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26573.
    PubMed     Abstract available


  133. WORKMAN AD, Soylu S, Kamani D, Nourmahnad A, et al
    Limitations of preoperative cytology for medullary thyroid cancer: Proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26550.
    PubMed     Abstract available


    November 2020
  134. YI X, Chen W, Li C, Chen X, et al
    Circular RNA circ_0004507 contributes to laryngeal cancer progression and cisplatin resistance by sponging miR-873 to upregulate multidrug resistance 1 and multidrug resistance protein 1.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26549.
    PubMed     Abstract available


  135. ZHANG Z, Xia F, Wang W, Jiang B, et al
    Ambulatory thyroidectomy is safe and beneficial in papillary thyroid carcinoma: Randomized controlled trial.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26557.
    PubMed     Abstract available


  136. RITTER A, Badir S, Mansour M, Segal Z, et al
    Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.
    Head Neck. 2020 Nov 27. doi: 10.1002/hed.26546.
    PubMed     Abstract available


  137. AKALI NR, Buggaveeti R, Sukumaran SV, Balasubramanian D, et al
    Prior chemoradiotherapy and pathological perineural invasion predict the survival outcomes of salvage surgery in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 21. doi: 10.1002/hed.26547.
    PubMed     Abstract available


  138. JURICA JM, Rubio F, Hernandez DJ, Sandulache VC, et al
    Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 9. doi: 10.1002/hed.26539.
    PubMed     Abstract available


  139. CARRON J, Torricelli C, Silva JK, Queiroz GSR, et al
    microRNAs deregulation in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 6. doi: 10.1002/hed.26533.
    PubMed     Abstract available


  140. ADEOYE J, Wan CCJ, Thomson P
    Mock clinical testing in the validation of fluid-phase biomarkers for head and neck carcinoma diagnosis: A Scoping review.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26526.
    PubMed     Abstract available


  141. YUAN X, Zhang L, Huang Y, Liu D, et al
    Induction of interleukin-6 by irradiation and its role in epithelial mesenchymal transition and radioresistance of nasopharyngeal carcinoma cells.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26531.
    PubMed     Abstract available


  142. HU CY, Wang WM, Chu XH, Ren ZH, et al
    Global, regional, and national burden of nasopharyngeal carcinoma from 1990 to 2017-Results from the Global Burden of Disease Study 2017.
    Head Neck. 2020;42:3243-3252.
    PubMed     Abstract available


    October 2020
  143. MOSES LE, Oliver JR, Rotsides JM, Shao Q, et al
    Nodal disease burden and outcome of medullary thyroid carcinoma.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26511.
    PubMed     Abstract available


  144. CAVALIERI S, De Cecco L, Brakenhoff RH, Serafini MS, et al
    Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26515.
    PubMed     Abstract available


  145. MULDER FJ, Pierssens DDCG, Baijens LWJ, Kremer B, et al
    Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta-analysis on HPV, p16, and TP53.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26513.
    PubMed     Abstract available


  146. MARGALIT DN, Sacco AG, Cooper JS, Ridge JA, et al
    Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26490.
    PubMed     Abstract available


  147. LIU W, Qdaisat A, Zhou S, Fuller CD, et al
    Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26510.
    PubMed     Abstract available


  148. KONO M, Wakisaka R, Kumai T, Hayashi R, et al
    Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy.
    Head Neck. 2020 Oct 5. doi: 10.1002/hed.26502.
    PubMed     Abstract available


  149. GADKAREE SK, McCarty JC, Feng AL, Siu JM, et al
    Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 4. doi: 10.1002/hed.26495.
    PubMed     Abstract available


  150. WANG Z, Yuan H, Huang J, Hu D, et al
    Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 3. doi: 10.1002/hed.26474.
    PubMed     Abstract available


  151. OKANO W, Hayashi R, Matsuura K, Shinozaki T, et al
    Extent of salvage neck dissection following chemoradiation for locally advanced head and neck cancer.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26494.
    PubMed     Abstract available


  152. KARATAS OF, Capik O, Barlak N, Aydin Karatas E, et al
    Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26493.
    PubMed     Abstract available


  153. JEANS C, Ward EC, Brown B, Vertigan AE, et al
    Association between external and internal lymphedema and chronic dysphagia following head and neck cancer treatment.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26484.
    PubMed     Abstract available


  154. SYKES KJ, Morrow E, Smith JB, Holcomb AJ, et al
    What is the hold up?-Mixed-methods analysis of postoperative radiotherapy delay in head and neck cancer.
    Head Neck. 2020;42:2948-2957.
    PubMed     Abstract available


    September 2020
  155. SVAJDOVA M, Dubinsky P, Kazda T
    Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review.
    Head Neck. 2020 Sep 30. doi: 10.1002/hed.26485.
    PubMed     Abstract available


  156. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
    Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26468.
    PubMed     Abstract available


  157. LEE DY, Abraham J, Ross E, Ridge JA, et al
    Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcome.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26479.
    PubMed     Abstract available


  158. LIU YP, Wang SL, Zou X, You R, et al
    Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence.
    Head Neck. 2020 Sep 28. doi: 10.1002/hed.26459.
    PubMed     Abstract available


  159. MHASKAR R, Caputo MP, Mifsud MJ
    Reply to Letter to the Editor regarding "Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis".
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26446.
    PubMed    


  160. HUANG GJ, Kong XY
    Diabetes mellitus in major head and neck cancer surgery.
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26451.
    PubMed    


  161. KRIPLANI A, Lavery JA, Mishra A, Korenstein D, et al
    Trends in chronic opioid therapy among survivors of head and neck cancer.
    Head Neck. 2020 Sep 22. doi: 10.1002/hed.26478.
    PubMed     Abstract available


  162. LIAO AH, Lin WT, Chen HK, Shih CP, et al
    Synergistic effects of combined treatment with ultrasound-mediated cisplatin-loaded microbubbles and atorvastatin on head and neck cancer.
    Head Neck. 2020 Sep 21. doi: 10.1002/hed.26445.
    PubMed     Abstract available


  163. LUO Y, Ma J, Liu F, Guo J, et al
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma.
    Head Neck. 2020 Sep 18. doi: 10.1002/hed.26441.
    PubMed     Abstract available


  164. ZOLKIND P, Lee JJ, Jackson RS, Pipkorn P, et al
    Untreated head and neck cancer: Natural history and associated factors.
    Head Neck. 2020 Sep 11. doi: 10.1002/hed.26460.
    PubMed     Abstract available


  165. RIJO-CEDENO J, Mucientes J, Alvarez O, Royuela A, et al
    Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta-analysis.
    Head Neck. 2020 Sep 11. doi: 10.1002/hed.26461.
    PubMed     Abstract available


  166. TAE K
    Reply to Letter to the Editor: Transoral robotic selective neck dissection for papillary thyroid carcinoma: Is it appropriate?
    Head Neck. 2020 Sep 5. doi: 10.1002/hed.26449.
    PubMed    


  167. PICCIN O, D'Alessio P, Cavicchi O
    Transoral robotic selective neck dissection for papillary thyroid carcinoma: Is it appropriate?
    Head Neck. 2020 Sep 5. doi: 10.1002/hed.26447.
    PubMed    


  168. HUANG GJ, Yang BB
    Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma.
    Head Neck. 2020 Sep 1. doi: 10.1002/hed.26388.
    PubMed    


  169. ZHU X
    Reply to Letter to the Editor regarding "Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis".
    Head Neck. 2020 Sep 1. doi: 10.1002/hed.26390.
    PubMed    


    August 2020
  170. LOPEZ EM, Tanner AM, Du E, Patel SN, et al
    Decline in circulating viral and human tumor markers after resection of head and neck carcinoma.
    Head Neck. 2020 Aug 28. doi: 10.1002/hed.26444.
    PubMed     Abstract available


  171. SU L, Lin Q, Li R, Hua Y, et al
    Prognostic value of nutritional impairment on treatment-related toxicity and survival in patients with nasopharyngeal carcinoma taking normal nutrition before radiotherapy.
    Head Neck. 2020 Aug 27. doi: 10.1002/hed.26426.
    PubMed     Abstract available


  172. CRAWFORD KL, Jafari A, Qualliotine JR, Stuart E, et al
    Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma.
    Head Neck. 2020 Aug 24. doi: 10.1002/hed.26418.
    PubMed     Abstract available


  173. ZHI-JUN X, Yue-Xiao L, Bo-Yu G, Ya-Tin J, et al
    Are contralateral submental artery perforator flaps feasible for the reconstruction of postoperative defects of oral cancer?
    Head Neck. 2020 Aug 22. doi: 10.1002/hed.26422.
    PubMed     Abstract available


  174. DOUGLAS CM, Jethwa AR, Hasan W, Liu A, et al
    Long-term survival of head and neck squamous cell carcinoma after bone marrow transplant.
    Head Neck. 2020 Aug 21. doi: 10.1002/hed.26402.
    PubMed     Abstract available


  175. STANISZ I, Janik S, Grasl MC, Erovic BM, et al
    Panendoscopy during follow-up in laryngeal carcinoma patients after radiotherapy.
    Head Neck. 2020 Aug 21. doi: 10.1002/hed.26433.
    PubMed     Abstract available


  176. ARBAB M, Chen YH, Criscitiello S, Glass J, et al
    Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin.
    Head Neck. 2020 Aug 19. doi: 10.1002/hed.26432.
    PubMed     Abstract available


  177. NABUURS CH, Kievit W, Labbe N, Leemans CR, et al
    Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26424.
    PubMed     Abstract available


  178. MALIK A, Nair S
    Reply to Letter to the Editor regarding "Soft tissue deposits in oral cancers".
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26412.
    PubMed    


  179. SMITH DK, Cmelak A, Niermann K, Ghiam M, et al
    Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation.
    Head Neck. 2020 Aug 7. doi: 10.1002/hed.26407.
    PubMed     Abstract available


  180. URABE M, Ueno M, Udagawa H
    Incidental identification of cervical nodal metastases from papillary thyroid carcinoma: Experiences related to esophageal cancer surgery.
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26392.
    PubMed    


  181. SHAH J
    Reply to the Letter to the Editor regarding "Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens".
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26391.
    PubMed    


  182. DU C, Tao Y
    Response to comments HN-20-1003 "Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma: useful treatment option with a caveat".
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26408.
    PubMed    


  183. CHAKRABORTY A, Thiagarajan S
    Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma-Useful treatment option with a caveat.
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26413.
    PubMed    


  184. KRAFT S, Gadkaree SK, Deschler DG, Lin DT, et al
    Programmed cell death ligand-1 and cytotoxic T cell infiltrates in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2020 Aug 1. doi: 10.1002/hed.26370.
    PubMed     Abstract available


    July 2020
  185. JEANS C, Brown B, Ward EC, Vertigan AE, et al
    Comparing the prevalence, location, and severity of head and neck lymphedema after postoperative radiotherapy for oral cavity cancers and definitive chemoradiotherapy for oropharyngeal, laryngeal, and hypopharyngeal cancers.
    Head Neck. 2020 Jul 31. doi: 10.1002/hed.26394.
    PubMed     Abstract available


  186. KARAN N, Siddiqui S, Sharma KS, Pantvaidya GH, et al
    Evaluation and validation of Physiological and Operative Severity Score for the enumeration of mortality and morbidity and Portsmouth-POSSUM scores in predicting morbidity and mortality in patients undergoing head and neck cancer surgeries.
    Head Neck. 2020 Jul 27. doi: 10.1002/hed.26354.
    PubMed     Abstract available


  187. GOGINENI E, Rana Z, Vempati P, Karten J, et al
    Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.
    Head Neck. 2020 Jul 21. doi: 10.1002/hed.26342.
    PubMed     Abstract available


  188. DEUTSCH FT, Khoury SJ, Sunwoo JB, Elliott MS, et al
    Application of salivary noncoding microRNAs for the diagnosis of oral cancers.
    Head Neck. 2020 Jul 20. doi: 10.1002/hed.26348.
    PubMed     Abstract available


  189. LINDEGAARD AM, von Buchwald C, Rasmussen JH, Specht L, et al
    Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer.
    Head Neck. 2020 Jul 18. doi: 10.1002/hed.26361.
    PubMed     Abstract available


  190. UEKI Y, Takahashi T, Ota H, Shodo R, et al
    Role of programmed death-ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26374.
    PubMed     Abstract available


  191. DAGAN O, Moore A, Nachlon Y, Alkan U, et al
    Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26353.
    PubMed     Abstract available


  192. CAPUTO MP, Shabani S, Mhaskar R, McMullen C, et al
    Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26349.
    PubMed     Abstract available


  193. LE ROUX MK, Graillon N, Guyot L, Taieb D, et al
    Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26359.
    PubMed     Abstract available


  194. TAE K, Kim KH
    Transoral robotic selective neck dissection for papillary thyroid carcinoma: Dissection of Levels III and IV.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26379.
    PubMed     Abstract available


  195. HOLMES BJ, von Eyben R, Attardi LD, Kong CS, et al
    Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26358.
    PubMed     Abstract available


  196. MUSORO JZ, Coens C, Singer S, Tribius S, et al
    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
    Head Neck. 2020 Jul 6. doi: 10.1002/hed.26363.
    PubMed     Abstract available


  197. FARQUHAR DR, Lenze NR, Masood MM, Divaris K, et al
    Access to preventive care services and stage at diagnosis in head and neck cancer.
    Head Neck. 2020 Jul 3. doi: 10.1002/hed.26326.
    PubMed     Abstract available


  198. LANDIN D, Ahrlund-Richter A, Mirzaie L, Mints M, et al
    Immune related proteins and tumor infiltrating CD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome.
    Head Neck. 2020 Jul 1. doi: 10.1002/hed.26364.
    PubMed     Abstract available


  199. KARLIGKIOTIS A, Arosio AD, Battaglia P, Sileo G, et al
    Changing paradigms in sinus and skull base surgery as the COVID-19 pandemic evolves: Preliminary experience from a single Italian tertiary care center.
    Head Neck. 2020;42:1610-1620.
    PubMed     Abstract available


  200. LAYFIELD E, Triantafillou V, Prasad A, Deng J, et al
    Telemedicine for head and neck ambulatory visits during COVID-19: Evaluating usability and patient satisfaction.
    Head Neck. 2020;42:1681-1689.
    PubMed     Abstract available


  201. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Locatelli D, et al
    Managing care for patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic.
    Head Neck. 2020;42:1503-1506.
    PubMed     Abstract available


    June 2020
  202. FERRANDINO RM, Roof S, Garneau J, Haidar Y, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck.
    Head Neck. 2020 Jun 27. doi: 10.1002/hed.26329.
    PubMed     Abstract available


  203. LEON X, Neumann E, Gutierrez A, Garcia J, et al
    Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV-negative head and neck squamous cell carcinoma patients.
    Head Neck. 2020 Jun 26. doi: 10.1002/hed.26340.
    PubMed     Abstract available


  204. WEINSTEIN GS, Cohen R, Lin A, O'Malley BW Jr, et al
    Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.
    Head Neck. 2020 Jun 25. doi: 10.1002/hed.26318.
    PubMed     Abstract available


  205. YEN CJ, Kiyota N, Hanai N, Takahashi S, et al
    Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141).
    Head Neck. 2020 Jun 24. doi: 10.1002/hed.26331.
    PubMed     Abstract available


  206. HOLCOMB AJ, Perryman M, Goodwin S, Penn J, et al
    Pathology protocol increases lymph node yield in neck dissection for oral cavity squamous cell carcinoma.
    Head Neck. 2020 Jun 24. doi: 10.1002/hed.26343.
    PubMed     Abstract available


  207. GRABOYES E, Cramer J, Balakrishnan K, Cognetti DM, et al
    COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon.
    Head Neck. 2020 Jun 20. doi: 10.1002/hed.26345.
    PubMed     Abstract available


  208. OH J, Liu A, Tran E, Berthelet E, et al
    Association between nutritional risk index and outcomes for head and neck cancer patients receiving concurrent chemo-radiotherapy.
    Head Neck. 2020 Jun 20. doi: 10.1002/hed.26315.
    PubMed     Abstract available


  209. VAN DER GEER SJ, van Rijn PV, Roodenburg JLN, Dijkstra PU, et al
    Prognostic factors associated with a restricted mouth opening (trismus) in patients with head and neck cancer: Systematic review.
    Head Neck. 2020 Jun 18. doi: 10.1002/hed.26327.
    PubMed     Abstract available


  210. ALTERIO D, Volpe S, Marvaso G, Turturici I, et al
    Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.
    Head Neck. 2020 Jun 18. doi: 10.1002/hed.26319.
    PubMed     Abstract available



  211. Corrigendum to "Evaluation of oncologic outcomes in head and neck cancer patients > 80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment" [Head and Neck, 2019:41(12):4128-4135].
    Head Neck. 2020 Jun 17. doi: 10.1002/hed.26309.
    PubMed    


  212. CHOI Y, Ahn KJ, Jang J, Shin NY, et al
    Prognostic value of computed tomography-based volumetric body composition analysis in patients with head and neck cancer: Feasibility study.
    Head Neck. 2020 Jun 16. doi: 10.1002/hed.26310.
    PubMed     Abstract available


  213. PANNU JS, Simpson MC, Donovan CL, Adjei Boakye E, et al
    Sociodemographic correlates of head and neck cancer survival among patients with metastatic disease.
    Head Neck. 2020 Jun 16. doi: 10.1002/hed.26284.
    PubMed     Abstract available


  214. HALL JA, Rusten M, Abughazaleh RD, Wuertz B, et al
    Effects of PPAR-gamma agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies.
    Head Neck. 2020 Jun 9. doi: 10.1002/hed.26286.
    PubMed     Abstract available


  215. KEJNER AE, Li H, Li EY, Porterfield JZ, et al
    Reply to Letter to the Editor regarding "Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation".
    Head Neck. 2020 Jun 8. doi: 10.1002/hed.26156.
    PubMed    


  216. HUANG GJ, Huang ZH
    Treatment modality and outcomes in larynx cancer patients.
    Head Neck. 2020 Jun 8. doi: 10.1002/hed.26157.
    PubMed    


  217. YAN F, Byun YJ, Nguyen SA, Stalcup ST, et al
    Predictive value of computed tomography in identifying extranodal extension in human papillomavirus-positive versus human papillomavirus-negative head and neck cancer.
    Head Neck. 2020 Jun 2. doi: 10.1002/hed.26281.
    PubMed     Abstract available


  218. KAWASHITA Y, Morimoto S, Tashiro K, Soutome S, et al
    Risk factors associated with the development of aspiration pneumonia in patients receiving radiotherapy for head and neck cancer: retrospective study.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26314.
    PubMed     Abstract available


  219. FRIED J, Etter JL, Stenzel AE, Joseph JM, et al
    Physical inactivity and head and neck cancer mortality.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26283.
    PubMed     Abstract available


  220. DAY AT, Dahlstrom KR, Lee R, Karam-Hage M, et al
    Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26268.
    PubMed     Abstract available


  221. GALLI J, Settimi S, Tricarico L, Almadori G, et al
    Clinical and surgical management of patients with head and neck cancer in a COVID-19 dedicated center in Italy.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26263.
    PubMed     Abstract available


    May 2020
  222. MROUEH R, Tanskanen T, Haapaniemi A, Salo T, et al
    Familial cancer risk in family members and spouses of patients with early-onset head and neck cancer.
    Head Neck. 2020 May 30. doi: 10.1002/hed.26282.
    PubMed     Abstract available


  223. YAN F, Rauscher E, Hollinger A, Caputo MA, et al
    The role of head and neck cancer advocacy organizations during the COVID-19 pandemic.
    Head Neck. 2020 May 29. doi: 10.1002/hed.26287.
    PubMed     Abstract available


  224. PEI S, Chen L, Yang Y, Zhu X, et al
    Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis.
    Head Neck. 2020 May 27. doi: 10.1002/hed.26266.
    PubMed     Abstract available


  225. PAGEDAR NA, Kendell N, Christensen AJ, Thomsen TA, et al
    Head and neck cancer survivorship from the patient perspective.
    Head Neck. 2020 May 23. doi: 10.1002/hed.26265.
    PubMed     Abstract available


  226. FOKI E, Gangl K, Kranebitter V, Niederberger-Leppin V, et al
    Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26247.
    PubMed     Abstract available


  227. LEE J, Shin IS, Kim WC, Yoon WS, et al
    Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: Meta-analysis and systematic review.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26264.
    PubMed     Abstract available


  228. NILSEN ML, Clump DA 2nd, Kubik M, Losego K, et al
    Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.
    Head Neck. 2020 May 18. doi: 10.1002/hed.26256.
    PubMed     Abstract available


  229. VERMA N, Patel S, Osborn V, McBride S, et al
    Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26245.
    PubMed     Abstract available


  230. BOWMAN R, Crosby DL, Sharma A
    Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26260.
    PubMed     Abstract available


  231. QIN T, Koneva LA, Liu Y, Zhang Y, et al
    Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer.
    Head Neck. 2020 May 14. doi: 10.1002/hed.26244.
    PubMed     Abstract available


  232. CHANG CF, Ei-Sayed IH, George JR, Heaton CM, et al
    Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
    Head Neck. 2020 May 13. doi: 10.1002/hed.26249.
    PubMed     Abstract available


  233. PALERI V, Hardman J, Tikka T, Bradley P, et al
    Rapid implementation of an evidence-based remote triaging system for assessment of suspected head and neck cancer referrals and patients on follow up after treatment during the COVID-19 pandemic: A model for international collaboration.
    Head Neck. 2020 May 6. doi: 10.1002/hed.26219.
    PubMed     Abstract available


  234. KIM DH, Kim Y, Kim SW, Hwang SH, et al
    Use of narrowband imaging for the diagnosis and screening of laryngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2020 May 4. doi: 10.1002/hed.26186.
    PubMed     Abstract available


  235. CIVANTOS FJ, Leibowitz JM, Arnold DJ, Stubbs VC, et al
    Ethical Surgical Triage of Head and Neck Cancer Patients during the COVID-19 Pandemic.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26229.
    PubMed     Abstract available


  236. GUPTA A, Arora V, Nair D, Agrawal N, et al
    Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian Scenario.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26227.
    PubMed     Abstract available


  237. LEE AK, FRCSEd RHC, FRCSEd EHL, Cheng HK, et al
    Mitigation of Head and Neck Cancer Service Disruption During COVID-19 in Hong Kong Through Telehealth and Multi-institution Collaboration.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26226.
    PubMed     Abstract available


    April 2020
  238. MASSA ST, Pipkorn P, Jackson RS, Zevallos JP, et al
    Access to a regular medical provider among head and neck cancer survivors.
    Head Neck. 2020 Apr 30. doi: 10.1002/hed.26182.
    PubMed     Abstract available


  239. KU PK, Holsinger FC, Chan JY, Yeung ZC, et al
    Management of Dysphagia in The Head and Neck Cancer Patient during COVID-19 Pandemic: A Practical Strategy.
    Head Neck. 2020 Apr 29. doi: 10.1002/hed.26224.
    PubMed     Abstract available


  240. PRASAD A, Brewster R, Newman JG, Rajasekaran K, et al
    Optimizing your telemedicine visit during the COVID-19 pandemic: Practice guidelines for patients with head and neck cancer.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26197.
    PubMed     Abstract available


  241. SHARMA A, Crosby DL
    Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26216.
    PubMed     Abstract available


  242. SILVERMAN DA, Lin C, Tamaki A, Puram SV, et al
    Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26217.
    PubMed     Abstract available


  243. CHOW VLY, Chan JYW, Ho VWY, Lee GCC, et al
    Conservation of personal protective equipment for head and neck cancer surgery during COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26215.
    PubMed     Abstract available


  244. SINGH AG, Deodhar J, Chaturvedi P
    Navigating the impact of COVID-19 on palliative care for head and neck cancer.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26211.
    PubMed     Abstract available


  245. YAN F, Nguyen SA
    Head and neck cancer: A high-risk population for COVID-19.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26209.
    PubMed    


  246. NOEL CW, Stephens RF, Su JS, Xu W, et al
    Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2020 Apr 25. doi: 10.1002/hed.26181.
    PubMed     Abstract available


  247. BHATTACHARJEE A, Patil VM, Dikshit R, Prabhash K, et al
    Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26196.
    PubMed     Abstract available


  248. SHUMAN AG, Campbell BH
    An Ethical Framework for Head and Neck Cancer Care Impacted by COVID-19.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26193.
    PubMed     Abstract available


  249. WANG L, Cao J, Wang X, Lin E, et al
    Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells.
    Head Neck. 2020 Apr 23. doi: 10.1002/hed.26155.
    PubMed     Abstract available


  250. DAI LB, Yu Q, Zhou SH, Bao YY, et al
    Effect of combination of curcumin and GLUT-1 AS-ODN on radiosensitivity of laryngeal carcinoma through regulating autophagy.
    Head Neck. 2020 Apr 21. doi: 10.1002/hed.26180.
    PubMed     Abstract available


  251. KLIGERMAN MP, Vukkadala N, Tsang RKY, Sunwoo JB, et al
    Managing the Head and Neck Cancer Patient with Tracheostomy or Laryngectomy During the COVID-19 Pandemic.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26171.
    PubMed    


  252. BOAKYE EA, Jenkins W, Sharma A
    Disproportionate impact of COVID-19 Pandemic on Head and Neck Cancer Survivors.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26170.
    PubMed    


  253. CIVANTOS AM, Carey RM, Lichtenstein GR, Lukens JN, et al
    Care of Immunocompromised Patients with Head and Neck Cancer During the COVID-19 Pandemic: Two Challenging and Informative Clinical Cases.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26165.
    PubMed     Abstract available


  254. RASSEKH CH, Jenks CM, Ochroch EA, Douglas JE, et al
    Management of the difficult airway in the COVID-19 pandemic: Illustrative complex head and neck cancer scenario.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26175.
    PubMed     Abstract available


  255. LEE MY, Allen CT
    Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer.
    Head Neck. 2020 Apr 10. doi: 10.1002/hed.26158.
    PubMed     Abstract available


    March 2020
  256. VENGALOOR THOMAS T, Packianathan S, Bhanat E, Albert A, et al
    Oligometastatic head and neck cancer: Comprehensive review.
    Head Neck. 2020 Mar 27. doi: 10.1002/hed.26144.
    PubMed     Abstract available


  257. FRANZ L, Tealdo G, Contro G, Bandolin L, et al
    Biological tumor markers (maspin, CD105, nm23-H1) and disease relapse in laryngeal cancer: cluster analysis.
    Head Neck. 2020 Mar 25. doi: 10.1002/hed.26152.
    PubMed     Abstract available


  258. PARK D, Kim HY, Kim HK, You JY, et al
    Institutional experience of 200 consecutive papillary thyroid carcinoma patients in transoral robotic thyroidectomy surgeries.
    Head Neck. 2020 Mar 25. doi: 10.1002/hed.26149.
    PubMed     Abstract available


  259. HE Y, Zhao Z, Wang Y, Chai J, et al
    Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis.
    Head Neck. 2020 Mar 23. doi: 10.1002/hed.26141.
    PubMed     Abstract available


  260. HUANG T, Su N, Zhang X, Ma S, et al
    Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases.
    Head Neck. 2020 Mar 10. doi: 10.1002/hed.26130.
    PubMed     Abstract available


  261. MEHRA R, Huang H, Seal B, Tse J, et al
    Real-world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno-oncology therapy.
    Head Neck. 2020 Mar 9. doi: 10.1002/hed.26126.
    PubMed     Abstract available


  262. PASALIC D, Betancourt-Cuellar SL, Taku N, Ludmir EB, et al
    Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
    Head Neck. 2020 Mar 4. doi: 10.1002/hed.26117.
    PubMed     Abstract available


  263. JACOMINA LE, Jacinto JKM, Co LBA, Yu KKL, et al
    The Role of postoperative external beam radiotherapy for differentiated thyroid carcinoma: A Systematic review and meta-analysis.
    Head Neck. 2020 Mar 4. doi: 10.1002/hed.26133.
    PubMed     Abstract available


    February 2020
  264. TOWNES TG, Navuluri S, Pytynia KB, Gunn GB, et al
    Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic.
    Head Neck. 2020 Feb 29. doi: 10.1002/hed.26119.
    PubMed     Abstract available


  265. KARSTEN RT, van der Molen L, Hamming-Vrieze O, van Son RJJH, et al
    Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update.
    Head Neck. 2020 Feb 29. doi: 10.1002/hed.26120.
    PubMed     Abstract available


  266. LOFHEDE H, Wertsen M, Havstam C
    Palatal augmentation prostheses in individuals treated for head and neck cancer: Effects on speech and oral transport.
    Head Neck. 2020 Feb 27. doi: 10.1002/hed.26124.
    PubMed     Abstract available


  267. THIBOUW F, Duvillard C, Thibouw D, Bertaut A, et al
    Evaluation of the quality of the information received during head and neck cancer announcement: Prospective two-center study.
    Head Neck. 2020 Feb 24. doi: 10.1002/hed.26109.
    PubMed     Abstract available


  268. WAN Y, Liu H, Zhang M, Huang Z, et al
    Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2020 Feb 12. doi: 10.1002/hed.26104.
    PubMed     Abstract available


  269. TEXAKALIDIS P, Giannopoulos S, Tsouknidas I, Song S, et al
    Prevalence of carotid stenosis following radiotherapy for head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2020 Feb 12. doi: 10.1002/hed.26102.
    PubMed     Abstract available


  270. MALIK A, Nair S, Singh A, Lamba K, et al
    Soft tissue deposit in neck dissection specimen carries a poor prognosis in oral cancer: A matched pair analysis.
    Head Neck. 2020 Feb 11. doi: 10.1002/hed.26103.
    PubMed     Abstract available


  271. BAO X, Liu F, Chen Q, Chen L, et al
    Propensity score analysis exploring the impact of smoking and drinking on the prognosis of patients with oral cancer.
    Head Neck. 2020 Feb 7. doi: 10.1002/hed.26099.
    PubMed     Abstract available


  272. AYLWARD A, Park J, Abdelaziz S, Hunt JP, et al
    Individualized prediction of late-onset dysphagia in head and neck cancer survivors.
    Head Neck. 2020 Feb 7. doi: 10.1002/hed.26039.
    PubMed     Abstract available


  273. TWU CW, Wang WY, Tsou HH, Liu YC, et al
    Effects of Epstein-Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma.
    Head Neck. 2020 Feb 3. doi: 10.1002/hed.26096.
    PubMed     Abstract available


  274. ILAPAKRUTY B, Rao VUS
    Is tailored management better than salvage in laryngeal squamous cell carcinomas.
    Head Neck. 2020;42:357.
    PubMed    


  275. MIMICA X, Hanson M, Cohen MA
    Reply to the letter of the editor: Is tailored management better than salvage in laryngeal squamous cell carcinomas?
    Head Neck. 2020;42:358-359.
    PubMed    


    January 2020
  276. RATURI V, Hojo H, Bhatt MLB, Suhel M, et al
    Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation.
    Head Neck. 2020 Jan 30. doi: 10.1002/hed.26083.
    PubMed     Abstract available


  277. SWIECICKI PL, Li P, Bellile E, Stucken C, et al
    Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
    Head Neck. 2020 Jan 27. doi: 10.1002/hed.26085.
    PubMed     Abstract available


  278. LIU YP, Xie YL, Zou X, You R, et al
    Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma.
    Head Neck. 2020 Jan 24. doi: 10.1002/hed.26090.
    PubMed     Abstract available


  279. SOLDERA EB, Ortigara GB, Bonzanini LIL, Schulz RE, et al
    Clinical and sociodemographic factors associated with oral health-related quality of life in survivors of head and neck cancer.
    Head Neck. 2020 Jan 21. doi: 10.1002/hed.26063.
    PubMed     Abstract available


  280. AHN D, Lee GJ, Sohn JH, Jeon JH, et al
    Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
    Head Neck. 2020 Jan 13. doi: 10.1002/hed.26075.
    PubMed     Abstract available


  281. COGNETTI DM, Villaflor VM, Fakhry C, Miller MC, et al
    Survivorship support in head and neck cancer: American Head and Neck Society survey.
    Head Neck. 2020 Jan 10. doi: 10.1002/hed.26066.
    PubMed     Abstract available


  282. ROMAN BR, Lohia S, Mitra N, Wang MB, et al
    Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.
    Head Neck. 2020 Jan 10. doi: 10.1002/hed.26071.
    PubMed     Abstract available


  283. BAHL A, Bhatia K, Choudhary P, Singhla S, et al
    Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis.
    Head Neck. 2020 Jan 8. doi: 10.1002/hed.26070.
    PubMed     Abstract available


  284. CHEE J, Liu X, Eu D, Loh T, et al
    Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes.
    Head Neck. 2020 Jan 7. doi: 10.1002/hed.26061.
    PubMed     Abstract available


  285. WALL LR, Ward EC, Cartmill B, Hill AJ, et al
    Prophylactic swallowing therapy for patients with head and neck cancer: A three-arm randomized parallel-group trial.
    Head Neck. 2020 Jan 6. doi: 10.1002/hed.26060.
    PubMed     Abstract available


  286. KOUDOUGOU C, Bertin H, Lecaplain B, Badran Z, et al
    Postimplantation radiation therapy in head and neck cancer patients: Literature review.
    Head Neck. 2020 Jan 3. doi: 10.1002/hed.26065.
    PubMed     Abstract available


  287. SULLIVAN CB, Al-Qurayshi Z, Pagedar NA
    Analysis of patients who decline treatment for squamous cell carcinoma of the head and neck: National perspective.
    Head Neck. 2020 Jan 2. doi: 10.1002/hed.26040.
    PubMed     Abstract available


  288. ILMARINEN T, Keski-Santti HT, Markkanen-Leppanen ML, Haapaniemi A, et al
    Reply to "Do not de-escalate oncology care in oropharyngeal cancer routinely".
    Head Neck. 2020;42:145-146.
    PubMed    


  289. SZTURZ P, Vermorken JB
    Do not de-escalate oncology care in oropharyngeal cancer routinely.
    Head Neck. 2020;42:143-144.
    PubMed    


    December 2019
  290. LEE YH, Goo-Yoshino S, Lew HL, Chi WC, et al
    Social participation in head and neck cancer survivors with swallowing disorder: World Health Organization Disability Assessment Schedule 2.0 study.
    Head Neck. 2019 Dec 30. doi: 10.1002/hed.26062.
    PubMed     Abstract available


  291. CHEN Q, Zou X, Ma Y, Liu F, et al
    Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection therapy for the treatment of chyle fistula following neck dissection.
    Head Neck. 2019 Dec 28. doi: 10.1002/hed.26054.
    PubMed     Abstract available


  292. MEHDIZADEH OB, Dhar SI, Evangelista L, Nativ-Zeltzer N, et al
    Prevalence of profound laryngeal sensory neuropathy in head and neck cancer survivors with feeding tube-dependent oropharyngeal dysphagia.
    Head Neck. 2019 Dec 27. doi: 10.1002/hed.26059.
    PubMed     Abstract available


  293. SUN C, Wang Q, Guo Q, Chang Q, et al
    Analysis of patterns and risk factors regarding the onset of nodules in the contralateral thyroid lobe during follow-up ultrasonography among patients after unilateral lobectomy for the treatment of papillary thyroid carcinoma.
    Head Neck. 2019 Dec 24. doi: 10.1002/hed.26056.
    PubMed     Abstract available


  294. RUEGG P, Morand GB, Kudura K, Rupp NJ, et al
    Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUVmax , p16-negativity, and low nodal shrinkage.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26045.
    PubMed     Abstract available


  295. MAKITIE AA, Almangush A, Youssef O, Metsala M, et al
    Exhaled breath analysis in the diagnosis of head and neck cancer.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26043.
    PubMed     Abstract available


  296. SAITO Y, Favorov AV, Forman M, Ren S, et al
    Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 18. doi: 10.1002/hed.26041.
    PubMed     Abstract available


  297. TIAN S, Switchenko JM, Fei T, Press RH, et al
    Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.
    Head Neck. 2019 Dec 16. doi: 10.1002/hed.26042.
    PubMed     Abstract available


  298. YANG TH, Xirasagar S, Cheng YF, Wu CS, et al
    Association between pioglitazone use and head and neck cancer: Population-based case-control study.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26046.
    PubMed     Abstract available


  299. NAGHAVI AO, Kim Y, Yang GQ, Ahmed KA, et al
    Alterations in genetic pathways following radiotherapy for head and neck cancer.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26004.
    PubMed     Abstract available


  300. ROGERS SN, Alvear A, Anesi A, Babin E, et al
    Variations in concerns reported on the patient concerns inventory in patients with head and neck cancer from different health settings across the world.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26027.
    PubMed     Abstract available


  301. DU C, Blanchard P, Even C, Boros A, et al
    Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 4. doi: 10.1002/hed.26021.
    PubMed     Abstract available


    November 2019
  302. WONG ECY, Hung JLC, Ng WT
    Potential pitfalls in incorporating plasma Epstein-Barr virus DNA in the management of nasopharyngeal carcinoma.
    Head Neck. 2019 Nov 28. doi: 10.1002/hed.26018.
    PubMed     Abstract available


  303. MARZILIANO A, Teckie S, Diefenbach MA
    Alcohol-related head and neck cancer: Summary of the literature.
    Head Neck. 2019 Nov 27. doi: 10.1002/hed.26023.
    PubMed     Abstract available


  304. PATEL JJ, Levy DA, Nguyen SA, Knochelmann HM, et al
    Impact of PD-L1 expression and human papillomavirus status in anti-PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma-Systematic review and meta-analysis.
    Head Neck. 2019 Nov 24. doi: 10.1002/hed.26036.
    PubMed     Abstract available


  305. STEPHENS RF, Noel CW, Su JS, Xu W, et al
    Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2019 Nov 24. doi: 10.1002/hed.26031.
    PubMed     Abstract available


  306. AGHAJANZADEH S, Karlsson T, Tuomi L, Finizia C, et al
    The effect of jaw exercises on anxiety and depression in patients with head and neck cancer receiving radiotherapy: Prospective 2-year follow-up study.
    Head Neck. 2019 Nov 22. doi: 10.1002/hed.26012.
    PubMed     Abstract available


  307. COCA-PELAZ A, Rodrigo JP, Suarez C, Nixon IJ, et al
    The risk of second primary tumors in head and neck cancer: A systematic review.
    Head Neck. 2019 Nov 21. doi: 10.1002/hed.26016.
    PubMed     Abstract available


  308. VALERO C, Pardo L, Sansa A, Garcia Lorenzo J, et al
    Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.
    Head Neck. 2019 Nov 21. doi: 10.1002/hed.26010.
    PubMed     Abstract available


  309. PODEUR F, Pommier P, Crozes C, Monchet E, et al
    Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes.
    Head Neck. 2019 Nov 18. doi: 10.1002/hed.26007.
    PubMed     Abstract available


  310. NEVES-SILVA R, Almeida LY, Silveira HA, Colturato CBN, et al
    SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
    Head Neck. 2019 Nov 15. doi: 10.1002/hed.26008.
    PubMed     Abstract available


  311. ZHANG Y, Xu S, Liu W, Wang X, et al
    Rational choice of neck dissection in clinically N0 patients with supraglottic cancer.
    Head Neck. 2019 Nov 14. doi: 10.1002/hed.26014.
    PubMed     Abstract available


  312. WANG L, Yang L, Han S, Zhu J, et al
    Patterns of protein expression in human head and neck cancer cell lines differ after proton vs photon radiotherapy.
    Head Neck. 2019 Nov 11. doi: 10.1002/hed.26005.
    PubMed     Abstract available


  313. BONOMO P, Talamonti C, Desideri I, Marrazzo L, et al
    Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy.
    Head Neck. 2019 Nov 4. doi: 10.1002/hed.25997.
    PubMed     Abstract available


  314. HURTADO-LOPEZ LM, Basurto-Kuba E
    In response: Tailored approach for recurrent laryngeal nerve dissection according to different endoscopic endocrine surgery.
    Head Neck. 2019;41:4062-4063.
    PubMed    


  315. MICCOLI P, Dionigi G
    Tailored approach for recurrent laryngeal nerve dissection according to different endoscopic endocrine surgery.
    Head Neck. 2019;41:4060-4061.
    PubMed    


    October 2019
  316. WILSON TG, Hanna A, Recknagel J, Pruetz BL, et al
    Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation.
    Head Neck. 2019 Oct 27. doi: 10.1002/hed.25983.
    PubMed     Abstract available


  317. HORI Y, Kubota A, Yokose T, Furukawa M, et al
    Association between pathological invasion patterns and late lymph node metastases in patients with surgically treated clinical No early oral tongue carcinoma.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25994.
    PubMed     Abstract available


  318. JANTHARAPATTANA K, Orapipatpong O
    Efficacy of EPA-enriched supplement compared with standard formula on body weight changes in malnourished patients with head and neck cancer undergone surgery: a randomized study.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25987.
    PubMed     Abstract available


  319. GOU X, Duan B, Shi H, Qin L, et al
    The relations of dosimetric parameters with long-term outcomes and late toxicities in advanced T-stage nasopharyngeal carcinoma with IMRT.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25986.
    PubMed     Abstract available


  320. PAIAR F, Cristaudo A, Gonnelli A, Giannini N, et al
    Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review".
    Head Neck. 2019 Oct 21. doi: 10.1002/hed.25982.
    PubMed     Abstract available


  321. NG WT, Lee MC, Fung NT, Wong EC, et al
    Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma.
    Head Neck. 2019 Oct 16. doi: 10.1002/hed.25988.
    PubMed     Abstract available


  322. DOOLEY BJ, Karassawa Zanoni D, Mcgill MR, Awad MI, et al
    Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer.
    Head Neck. 2019 Oct 8. doi: 10.1002/hed.25970.
    PubMed     Abstract available


  323. PARK H, Harries V, McGill MR, Ganly I, et al
    Isthmusectomy in selected patients with well-differentiated thyroid carcinoma.
    Head Neck. 2019 Oct 7. doi: 10.1002/hed.25968.
    PubMed     Abstract available


  324. AMINI A, Verma V, Li R, Vora N, et al
    Factors predicting for patient refusal of head and neck cancer therapy.
    Head Neck. 2019 Oct 4. doi: 10.1002/hed.25966.
    PubMed     Abstract available


  325. KAO HF, Lou PJ
    Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.
    Head Neck. 2019;41 Suppl 1:4-18.
    PubMed     Abstract available


  326. LOU PJ
    Preface for the special issue of "Immunotherapy for head and neck cancers: Current landscapes, emerging biomarkers, and future directions".
    Head Neck. 2019;41 Suppl 1:3.
    PubMed    


  327. CHEN TH, Chang PM, Yang MH
    Novel immune-modulating drugs for advanced head and neck cancer.
    Head Neck. 2019;41 Suppl 1:46-56.
    PubMed     Abstract available


  328. HSIEH JC, Wang HM, Wu MH, Chang KP, et al
    Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy.
    Head Neck. 2019;41 Suppl 1:19-45.
    PubMed     Abstract available


  329. NISHIO N, van Keulen S, van den Berg NS, Lu G, et al
    Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
    Head Neck. 2019 Oct 1. doi: 10.1002/hed.25964.
    PubMed     Abstract available


  330. ORLANDI E, Iacovelli NA, Cavallo A, Resteghini C, et al
    Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression?
    Head Neck. 2019;41:3733-3735.
    PubMed    


    September 2019
  331. BALAGUER M, Pommee T, Farinas J, Pinquier J, et al
    Effects of oral and oropharyngeal cancer on speech intelligibility using acoustic analysis: Systematic review.
    Head Neck. 2019 Sep 30. doi: 10.1002/hed.25949.
    PubMed     Abstract available


  332. HAN JE, Yi SK, Wang S, Erman A, et al
    Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.
    Head Neck. 2019 Sep 14. doi: 10.1002/hed.25955.
    PubMed     Abstract available


  333. WU L, Zhuo S, Zeng W, Liang S, et al
    Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
    Head Neck. 2019 Sep 13. doi: 10.1002/hed.25953.
    PubMed     Abstract available


  334. RODEN D, Daniels K, Metkus J, Goldman R, et al
    Evaluation of oncologic outcomes in head and neck cancer patients >/=80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25950.
    PubMed     Abstract available


  335. MOWERY AJ, Conlin MJ, Clayburgh DR
    Elevated incidence of head and neck cancer in solid organ transplant recipients.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25937.
    PubMed     Abstract available


  336. GIRKAR F, Thiagarajan S, Malik A, Sawhney S, et al
    Factors predisposing to the development of orocutaneous fistula following surgery for oral cancer: Experience from a tertiary cancer center.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25951.
    PubMed     Abstract available


  337. TAM S, Nurgalieva Z, Weber RS, Lewis CM, et al
    Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25936.
    PubMed     Abstract available


  338. BRISSON RJ, Kochanny S, Arshad S, Dekker A, et al
    A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Sep 4. doi: 10.1002/hed.25910.
    PubMed     Abstract available


  339. MASKELL D, Buckley H, Sisson K, Roques T, et al
    In reply to McDowell et al.
    Head Neck. 2019;41:3470-3471.
    PubMed    


  340. MCDOWELL L, Corry J
    Comment on "Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer-Approach with caution".
    Head Neck. 2019;41:3468-3469.
    PubMed    


    August 2019
  341. KARSTEN RT, Al-Mamgani A, Bril SI, Tjon-A-Joe S, et al
    Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer.
    Head Neck. 2019 Aug 31. doi: 10.1002/hed.25938.
    PubMed     Abstract available


  342. XU SY, Yao JJ, Zhou W, Chen L, et al
    Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion.
    Head Neck. 2019 Aug 29. doi: 10.1002/hed.25941.
    PubMed     Abstract available


  343. ELDRIDGE RC, Pugh SL, Trotti A, Hu K, et al
    Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25922.
    PubMed     Abstract available


  344. CHEN JH, Huang WY, Ho CL, Chao TY, et al
    Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25904.
    PubMed     Abstract available


  345. MIMICA X, Hanson M, Patel SG, McGill M, et al
    Salvage surgery for recurrent larynx cancer.
    Head Neck. 2019 Aug 21. doi: 10.1002/hed.25925.
    PubMed     Abstract available


  346. CHO Y, Yoon HI, Lee IJ, Kim JW, et al
    Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes.
    Head Neck. 2019 Aug 20. doi: 10.1002/hed.25928.
    PubMed     Abstract available


  347. TAN AL, Iyer NG, Putri N, Nadkarni N, et al
    Factors driving frequent attendance at emergency departments for patients with head and neck cancer.
    Head Neck. 2019 Aug 18. doi: 10.1002/hed.25916.
    PubMed     Abstract available


  348. SHAH M, Jomaa MK, Ferrarotto R, Yeung SJ, et al
    Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review.
    Head Neck. 2019 Aug 15. doi: 10.1002/hed.25911.
    PubMed     Abstract available


  349. GILL AS, Kinzinger M, Bewley AF, Farwell DG, et al
    Malnutrition evaluation in head and neck cancer patients: Practice patterns among otolaryngologists and radiation oncologists.
    Head Neck. 2019 Aug 12. doi: 10.1002/hed.25909.
    PubMed     Abstract available


  350. LIN DJ, Lam A, Warner L, Paleri V, et al
    Elective neck dissection in patients with radio-recurrent and radio-residual squamous cell carcinoma of the larynx undergoing salvage total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2019 Aug 10. doi: 10.1002/hed.25907.
    PubMed     Abstract available


  351. ALMADORI G, De Corso E, Visconti G, Almadori A, et al
    Impact of internal mammary artery perforator propeller flap in neck resurfacing and fistula closure after salvage larynx cancer surgery: Our experience.
    Head Neck. 2019 Aug 9. doi: 10.1002/hed.25903.
    PubMed     Abstract available


  352. LI H, Li EY, Kejner AE
    Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25897.
    PubMed     Abstract available


  353. MANDAPATHIL M, Lennon P, Ganly I, Patel SG, et al
    Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25905.
    PubMed     Abstract available


  354. MASCARELLA MA, Azzi JL, da Silva SD, Mlynarek A, et al
    Postoperative infection predicts poor survival in locoregionally advanced oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25885.
    PubMed     Abstract available


  355. MCGURK M
    Surgical consensus guidelines on sentinel node biopsy in patients with oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25898.
    PubMed    


  356. KWAN BYM, Khan NM, de Almeida JR, Goldstein D, et al
    Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup.
    Head Neck. 2019 Aug 1. doi: 10.1002/hed.25887.
    PubMed     Abstract available


    July 2019
  357. JAKOB M, Mattes LM, Kuffer S, Unger K, et al
    MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25866.
    PubMed     Abstract available


  358. ORLANDI E, Bonomo P, Ferella L, D'Angelo E, et al
    Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25890.
    PubMed     Abstract available


  359. LE GUEVELOU J, Lebars S, Kammerer E, de Gabory L, et al
    Head and neck cancer during pregnancy.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25877.
    PubMed     Abstract available


  360. MAKITIE AA, Almangush A, Rodrigo JP, Ferlito A, et al
    Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25872.
    PubMed     Abstract available


  361. LU T, Xie X, Guo Q, Zhan S, et al
    Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25865.
    PubMed     Abstract available


  362. PAULI N, Mejersjo C, Fagerberg-Mohlin B, Finizia C, et al
    Temporomandibular disorder in head and neck cancer patients undergoing radiotherapy: Clinical findings and patient-reported symptoms.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25878.
    PubMed     Abstract available


  363. MARIONI G, Nicole L, Cazzador D, Pavone C, et al
    Endoglin (CD105) expression in neurofibromatosis type 2 vestibular schwannoma.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25881.
    PubMed     Abstract available


  364. RASSY E, Nicolai P, Pavlidis N
    Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.
    Head Neck. 2019 Jul 13. doi: 10.1002/hed.25858.
    PubMed     Abstract available


  365. LI X, Zhou J, Chu C, You Q, et al
    Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy.
    Head Neck. 2019 Jul 12. doi: 10.1002/hed.25861.
    PubMed     Abstract available


  366. PETRUZZI G, Zocchi J, Moretto S, Pichi B, et al
    Transoral robotic retropharyngeal lymph node dissection in a recurrent head and neck carcinoma.
    Head Neck. 2019 Jul 11. doi: 10.1002/hed.25874.
    PubMed     Abstract available


  367. ABOUYARED M, Katz AP, Ein L, Ketner J, et al
    Controversies in free tissue transfer for head and neck cancer: A review of the literature.
    Head Neck. 2019 Jul 9. doi: 10.1002/hed.25853.
    PubMed     Abstract available


  368. KIM SH, Lee WH, Seong D, An JH, et al
    The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation.
    Head Neck. 2019 Jul 3. doi: 10.1002/hed.25868.
    PubMed     Abstract available


  369. SU Z, Cao X, Zou G
    Brain and frontal-bone metastasis from nasopharyngeal carcinoma: Case report and literature review.
    Head Neck. 2019 Jul 2. doi: 10.1002/hed.25859.
    PubMed     Abstract available


    June 2019
  370. WANG JR, Nurgalieva Z, Fu S, Tam S, et al
    Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis.
    Head Neck. 2019 Jun 25. doi: 10.1002/hed.25844.
    PubMed     Abstract available


  371. MOORE P, Grinsell D, Lyons B, Hewson I, et al
    Outcomes of dental and craniofacial osseointegrated implantation in head and neck cancer patients.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25845.
    PubMed     Abstract available


  372. WATTERS AL, Cope S, Keller MN, Padilla M, et al
    Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-analysis.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25836.
    PubMed     Abstract available


  373. OH J, Prisman E, Olson R, Berthelet E, et al
    Primary organ preservation vs total laryngectomy for T4a larynx cancer.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25838.
    PubMed     Abstract available


  374. HU Y, Lu T, Huang SH, Lin S, et al
    High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma.
    Head Neck. 2019 Jun 17. doi: 10.1002/hed.25842.
    PubMed     Abstract available


  375. WANG KY, Yang KC, Su FY, Chen YC, et al
    Association between blood pressure and postoperative hematomas in the patients undergoing head and neck cancer reconstruction.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25831.
    PubMed     Abstract available


  376. MIROSEVIC S, Thewes B, van Herpen C, Kaanders J, et al
    Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25812.
    PubMed     Abstract available


  377. POWROZEK T, Brzozowska A, Mazurek M, Mlak R, et al
    Combined analysis of miRNA-181a with phase angle derived from bioelectrical impedance predicts radiotherapy-induced changes in body composition and survival of male patients with head and neck cancer.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25830.
    PubMed     Abstract available


  378. VUONG HG, Ho ATN, Tran TTK, Capdevila J, et al
    Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25832.
    PubMed     Abstract available


    May 2019
  379. CHEN JL, Shen CW, Wang CC, Huang YS, et al
    Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study.
    Head Neck. 2019 May 22. doi: 10.1002/hed.25814.
    PubMed     Abstract available


  380. DELAHAUT G, Temam S, Ambroise J, Tao Y, et al
    Prognostic impact of tumor growth velocity in head and neck squamous cell carcinoma treated by radiotherapy: A pilot study.
    Head Neck. 2019 May 14. doi: 10.1002/hed.25789.
    PubMed     Abstract available


  381. JACOBI C, Gahleitner C, Bier H, Knopf A, et al
    Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
    Head Neck. 2019 May 9. doi: 10.1002/hed.25796.
    PubMed     Abstract available


    April 2019
  382. DANIELS KE, Luginbuhl AJ, Mardekian SK, Cognetti DM, et al
    Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Apr 29. doi: 10.1002/hed.25794.
    PubMed     Abstract available


  383. VAN DE GOOR RMGE, Hardy JCA, van Hooren MRA, Kremer B, et al
    Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25787.
    PubMed     Abstract available


  384. HO YY, Wu TY, Cheng HC, Yang CC, et al
    The significance of tumor budding in oral cancer survival and its relevance to the eighth edition of the American Joint Committee on Cancer staging system.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25780.
    PubMed     Abstract available


  385. THAM T, Machado R, Herman SW, Kraus D, et al
    Personalized prognostication in head and neck cancer: A systematic review of nomograms according to the AJCC precision medicine core (PMC) criteria.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25778.
    PubMed     Abstract available


  386. SONG YC, Hung KF, Liang KL, Chiang JH, et al
    Adjunctive Chinese herbal medicine therapy for nasopharyngeal carcinoma: Clinical evidence and experimental validation.
    Head Neck. 2019 Apr 15. doi: 10.1002/hed.25766.
    PubMed     Abstract available


  387. DURAN G, Aguin S, Cruz R, Barros F, et al
    Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
    Head Neck. 2019 Apr 11. doi: 10.1002/hed.25754.
    PubMed     Abstract available


  388. DE KORT WWB, Maas SLN, Van Es RJJ, Willems SM, et al
    Prognostic value of the nodal yield in head and neck squamous cell carcinoma: A systematic review.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25764.
    PubMed     Abstract available


  389. MIYAGAWA Y, Araki K, Yamashita T, Tanaka S, et al
    Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virus.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25769.
    PubMed     Abstract available


  390. CHEN F, Yan L, Wang J, Lin L, et al
    Upregulated long noncoding RNA ENST00000470447.1 inhibits cell migration and invasion and predicts better disease-free survival of oral cancer.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25765.
    PubMed     Abstract available


  391. PANDA S, Thakar A, Sikka K, Sharma SC, et al
    Role of sternomastoid muscle interposition in concomitant transoral oncologic resection and neck dissection.
    Head Neck. 2019 Apr 4. doi: 10.1002/hed.25753.
    PubMed     Abstract available


    March 2019
  392. YOUNG LK, Vimawala S, Ahmad N, Kushnir V, et al
    Review of inbound medical tourism and legal details of obtaining a visa for treatment of head and neck cancer.
    Head Neck. 2019 Mar 25. doi: 10.1002/hed.25743.
    PubMed     Abstract available


  393. COSTA EFD, Lopes-Aguiar L, Nogueira GS, Lima TRP, et al
    CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 23. doi: 10.1002/hed.25746.
    PubMed     Abstract available


  394. WANG HM, Wu MH, Chang PH, Lin HC, et al
    The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.
    Head Neck. 2019 Mar 22. doi: 10.1002/hed.25744.
    PubMed     Abstract available


  395. MEANS C, Clayburgh DR, Maloney L, Sauer D, et al
    Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25740.
    PubMed     Abstract available


  396. SCHILLING C, Stoeckli SJ, Vigili MG, de Bree R, et al
    Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25739.
    PubMed     Abstract available


  397. KIM H, Shin JH, Hahn SY, Oh YL, et al
    Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25721.
    PubMed     Abstract available


  398. HENRY M, Fuehrmann F, Hier M, Zeitouni A, et al
    Contextual and historical factors for increased levels of anxiety and depression in patients with head and neck cancer: A prospective longitudinal study.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25725.
    PubMed     Abstract available


  399. MORSE RT, Ganju RG, TenNapel MJ, Neupane P, et al
    Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 11. doi: 10.1002/hed.25717.
    PubMed     Abstract available


  400. JANG JY, Kim DS, Park HY, Shin SC, et al
    Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
    Head Neck. 2019 Mar 7. doi: 10.1002/hed.25729.
    PubMed     Abstract available


  401. BAI S, Zhang P, Zhang JC, Shen J, et al
    A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 6. doi: 10.1002/hed.25731.
    PubMed     Abstract available


  402. YASUMATSU R, Wakasaki T, Hashimoto K, Nakashima K, et al
    Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25737.
    PubMed     Abstract available


  403. MOHAMED A, Twardy B, Zordok MA, Ashraf K, et al
    Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: A comparative analysis.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25379.
    PubMed     Abstract available


  404. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25727.
    PubMed     Abstract available


  405. FADEN DL, Concha-Benavente F, Chakka AB, McMichael EL, et al
    Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25726.
    PubMed     Abstract available


  406. MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
    Effectiveness of chemoradiotherapy for radiation-induced bilateral external auditory canal cancer: A case report and literature review.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25728.
    PubMed     Abstract available


  407. VAN SCHAIK JE, Muller Kobold AC, van der Laan BFAM, van der Vegt B, et al
    Squamous cell carcinoma antigen concentration in fine needle aspiration samples: A new method to detect cervical lymph node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25733.
    PubMed     Abstract available


  408. MORATIN J, Metzger K, Safaltin A, Herpel E, et al
    Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 1. doi: 10.1002/hed.25713.
    PubMed     Abstract available


    February 2019
  409. TU HF, Chen MY, Lai JC, Chen YL, et al
    Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25718.
    PubMed     Abstract available


  410. MIRZA AH, Thomas G, Ottensmeier CH, King EV, et al
    Importance of the immune system in head and neck cancer.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25716.
    PubMed     Abstract available


  411. KAO LT, Hung SH, Kao PF, Liu JC, et al
    Inverse association between statin use and head and neck cancer: A population-based case-control study in Han population.
    Head Neck. 2019 Feb 26. doi: 10.1002/hed.25501.
    PubMed     Abstract available


  412. RODRIGUES-JUNIOR DM, Tan SS, Lim SK, de Souza Viana L, et al
    High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression.
    Head Neck. 2019 Feb 25. doi: 10.1002/hed.25510.
    PubMed     Abstract available


  413. ROBBINS KT, Medina J, Ferlito A
    Adding clarity to the historical evolution of the selective neck dissection.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25704.
    PubMed    


  414. STELZLE F, Oetter N, Goellner LT, Adler W, et al
    Speech intelligibility in patients with oral cancer: An objective baseline evaluation of pretreatment function and impairment.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25527.
    PubMed     Abstract available


  415. SMEE R, Williams JR, Kotevski DP
    Surgery is not the only determinant of an outcome in patients with hypopharyngeal carcinoma.
    Head Neck. 2019 Feb 21. doi: 10.1002/hed.25496.
    PubMed     Abstract available


  416. BATES JE, De Leo AN, Morris CG, Amdur RJ, et al
    Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.
    Head Neck. 2019 Feb 20. doi: 10.1002/hed.25695.
    PubMed     Abstract available


  417. WALD P, Grecula J, Walston S, Wei L, et al
    Intraoperative electron beam radiotherapy for locoregionally persistent or recurrent head and neck cancer.
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25673.
    PubMed     Abstract available


  418. TASSLER AB, Gooding WE, Ferris RL
    Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25687.
    PubMed     Abstract available


  419. SHAHA AR
    Recent historic perspective on modified neck dissection.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25700.
    PubMed    


  420. WANG B, Weng YJ, Wang SS, Zhao WX, et al
    Feasibility and safety of needle-assisted endoscopic thyroidectomy with lateral neck dissection for papillary thyroid carcinoma: a preliminary experience.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25705.
    PubMed     Abstract available


  421. KHARIWALA SS, Rubin N, Stepanov I, Nollen N, et al
    "Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.
    Head Neck. 2019 Feb 15. doi: 10.1002/hed.25708.
    PubMed     Abstract available


  422. VAN DEN STEEN L, Van Gestel D, Vanderveken O, Vanderwegen J, et al
    Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patients.
    Head Neck. 2019 Feb 14. doi: 10.1002/hed.25684.
    PubMed     Abstract available


  423. KIM HK, Park D, Kim HY
    Robotic transoral thyroidectomy: Total thyroidectomy and ipsilateral central neck dissection with da Vinci Xi Surgical System.
    Head Neck. 2019 Feb 13. doi: 10.1002/hed.25661.
    PubMed     Abstract available


  424. COCA-PELAZ A, Halmos GB, Strojan P, de Bree R, et al
    The role of age in treatment-related adverse events in patients with head and neck cancer: A systematic review.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25696.
    PubMed     Abstract available


  425. SUN W, Chen L, Huang JQ, Li J, et al
    Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25699.
    PubMed     Abstract available


  426. AVKSHTOL V, Handorf EA, Ridge JA, Leachman BK, et al
    Examining adjuvant radiation dose in head and neck squamous cell carcinoma.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25680.
    PubMed     Abstract available


  427. LIU J, Lu D, Deng D, Wang J, et al
    Free posterior tibial artery perforator flap for 2-stage tracheal reconstruction in patients after resection of well-differentiated thyroid carcinoma invading the trachea.
    Head Neck. 2019 Feb 6. doi: 10.1002/hed.25675.
    PubMed     Abstract available


  428. HUTCHISON AR, Cartmill B, Wall LR, Ward EC, et al
    Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: A systematized scoping review.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25688.
    PubMed     Abstract available


  429. MUELLER SA, Riggauer J, Elicin O, Blaser D, et al
    Patients' preferences concerning follow-up after curative head and neck cancer treatment: A cross-sectional pilot study.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25686.
    PubMed     Abstract available


  430. LI L, Sun Z, Huang X, Li X, et al
    Role of c-Met expression on prognosis of head and neck cancer: A literature review and meta-analysis.
    Head Neck. 2019 Feb 1. doi: 10.1002/hed.25655.
    PubMed     Abstract available


    January 2019
  431. STRIETH S, Ernst BP, Both I, Hirth D, et al
    Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer.
    Head Neck. 2019 Jan 31. doi: 10.1002/hed.25474.
    PubMed     Abstract available


  432. BUSSU F, Tagliaferri L, Mattiucci G, Parrilla C, et al
    HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25646.
    PubMed     Abstract available


  433. LANG S, Schimansky S, Beynon R, Penfold C, et al
    Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25660.
    PubMed     Abstract available


  434. ARBAB M, Margalit DN, Tishler RB, Rabinowits G, et al
    Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.
    Head Neck. 2019 Jan 29. doi: 10.1002/hed.25663.
    PubMed     Abstract available


  435. SWEGAL WC, Iwata AJ, Chang SS
    Developing a patient driven head and neck cancer care pathway.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25590.
    PubMed    


  436. MENDEZ LC, Conrad T, Lee J, Smith B, et al
    Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25624.
    PubMed     Abstract available


  437. DEN TOOM IJ, Janssen LM, van Es RJJ, Karagozoglu KH, et al
    Depth of invasion in patients with early stage oral cancer staged by sentinel node biopsy.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25665.
    PubMed     Abstract available


  438. RILEY CA, Marino MJ, Hsieh MC, Wu EL, et al
    Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease.
    Head Neck. 2019 Jan 25. doi: 10.1002/hed.25600.
    PubMed     Abstract available


  439. KLIGERMAN MP, Sethi RKV, Kozin ED, Gray ST, et al
    Morbidity and mortality among patients with head and neck cancer in the emergency department: A national perspective.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25534.
    PubMed     Abstract available


  440. MENNINI FS, Marcellusi A, Fabiano G, Platini F, et al
    Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25481.
    PubMed     Abstract available


  441. BUTTERWORTH CJ
    Primary vs secondary zygomatic implant placement in patients with head and neck cancer-A 10-year prospective study.
    Head Neck. 2019 Jan 21. doi: 10.1002/hed.25645.
    PubMed     Abstract available


  442. SOOD A, Wykes J, Roshan D, Wang LY, et al
    A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 19. doi: 10.1002/hed.25599.
    PubMed     Abstract available


  443. MIRABILE A, Miceli R, Calderone RG, Locati L, et al
    Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25636.
    PubMed     Abstract available


  444. KRAAIJENGA SA, Hamming-Vrieze O, Verheijen S, Lamers E, et al
    Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25573.
    PubMed     Abstract available


  445. HUANG HI, Chen CH, Wang SH, Wang LH, et al
    Effects of APE1 Asp148Glu polymorphisms on OPMD malignant transformation, and on susceptibility to and overall survival of oral cancer in Taiwan.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25576.
    PubMed     Abstract available


  446. FAGAN JJ, Otiti J, Aswani J, Konney A, et al
    African head and neck fellowships: A model for a sustainable impact on head and neck cancer care in developing countries.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25615.
    PubMed     Abstract available


  447. PAVON MA, Arroyo-Solera I, Leon X, Tellez-Gabriel M, et al
    The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25623.
    PubMed     Abstract available


  448. CABEZAS-CAMARERO S, Garcia-Barberan V, Saiz-Pardo Sanz M, Cabrera-Martin MN, et al
    Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25635.
    PubMed     Abstract available


  449. SU WW, Su CW, Chang DC, Chuang SL, et al
    Impact of varying anatomic sites on advanced stage and survival of oral cancer: A 9-year prospective cohort of 27 717 cases.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25579.
    PubMed     Abstract available


  450. BUGTER O, van Iwaarden DLP, Dronkers EAC, de Herdt MJ, et al
    Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25595.
    PubMed     Abstract available


  451. MEHTA V, Ow TJ, Kim S, Tharakan T, et al
    Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25596.
    PubMed     Abstract available


  452. SINGER S, Amdal CD, Hammerlid E, Tomaszewska IM, et al
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25609.
    PubMed     Abstract available


  453. LEE JW, Ban MJ, Park JH, Lee SM, et al
    Visceral adipose tissue volume and CT-attenuation as prognostic factors in patients with head and neck cancer.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25605.
    PubMed     Abstract available


  454. BECKHAM TH, Leeman J, Jillian Tsai C, Riaz N, et al
    Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: A series of 9 cases and review of the literature.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25577.
    PubMed     Abstract available


  455. CHAN JW, Yeh I, El-Sayed IH, Algazi AP, et al
    Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25613.
    PubMed     Abstract available


  456. VAN DAELE DJ, Langmore SE, Krisciunas GP, Lazarus CL, et al
    The impact of time after radiation treatment on dysphagia in patients with head and neck cancer enrolled in a swallowing therapy program.
    Head Neck. 2019 Jan 10. doi: 10.1002/hed.25344.
    PubMed     Abstract available


  457. TESHIMA M, Otsuki N, Shinomiya H, Morita N, et al
    Impact of retropharyngeal lymph node dissection in the surgical treatment of hypopharyngeal cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25608.
    PubMed     Abstract available


  458. XIANG ZZ, Liu F, Yan RN, Zeng YY, et al
    The prognostic value of volumetric reduction of the target lesions after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25620.
    PubMed     Abstract available


  459. IWATA AJ, Olden HA, Kippen KE, Swegal WC, et al
    A flexible model for patient engagement: Achieving quality outcomes and building a research agenda for head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25584.
    PubMed     Abstract available


  460. WHITE JM, Panchal NH, Wehler CJ, Bestgen SC, et al
    Department of Veterans Affairs Consensus: Preradiation dental treatment guidelines for patients with head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25519.
    PubMed     Abstract available


  461. INGARFIELD K, McMahon AD, Douglas CM, Savage SA, et al
    Determinants of long-term survival in a population-based cohort study of patients with head and neck cancer from Scotland.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25630.
    PubMed     Abstract available


  462. MONTES DE OCA MK, Nye A, Porter C, Collins J, et al
    Head and neck cancer PEG site metastases: Association with PEG placement method.
    Head Neck. 2019 Jan 7. doi: 10.1002/hed.25564.
    PubMed     Abstract available


  463. DENARO AN, Merlano MC
    Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25418.
    PubMed     Abstract available


  464. MAYFIELD JD, Mercado CE, Kaye FJ, Mendenhall WM, et al
    Cetuximab-associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25528.
    PubMed     Abstract available


    December 2018
  465. LIN CS, Chen YW, Liu SC, Tsao CC, et al
    Treatment outcomes with whole-field versus split-field intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.25328.
    PubMed     Abstract available


  466. GILL A, Givi BB, Moore MG
    AHNS Series - Do you know your guidelines?: Assessment and management of malnutrition in patients with head and neck cancer: A review of the NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines((R)) ).
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.24866.
    PubMed     Abstract available


  467. YANG L, Huang Y, Zhou L, Dai Y, et al
    High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25583.
    PubMed     Abstract available


  468. RAMOS-GARCIA P, Gonzalez-Moles MA, Ayen A, Gonzalez-Ruiz L, et al
    Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25632.
    PubMed     Abstract available


  469. TIAN YM, Liu MZ, Zeng L, Bai L, et al
    Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25545.
    PubMed     Abstract available


  470. BUGTER O, van de Ven SEM, Hardillo JA, Bruno MJ, et al
    Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25548.
    PubMed     Abstract available


  471. MIRZA AH, Aylin P, Middleton S, King EV, et al
    Impact of social deprivation on the outcome of major head and neck cancer surgery in England: A national analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25461.
    PubMed     Abstract available


  472. ALVES-PAIVA RM, Gutierrez-Rodrigues F, Pereira-Martins DA, Figueiredo DLA, et al
    Short telomere length in peripheral blood leukocytes in head and neck cancer: Findings in a Brazilian cohort.
    Head Neck. 2018 Dec 27. doi: 10.1002/hed.25472.
    PubMed     Abstract available


  473. CHOI SW, Ko H
    Primary Ewing sarcoma of the squamous temporal bone with intracranial and extracranial extension: A rare cause of sudden sensorineural hearing loss.
    Head Neck. 2018 Dec 24. doi: 10.1002/hed.25449.
    PubMed     Abstract available


  474. HOLLOWS R, Wei W, Cazier JB, Mehanna H, et al
    Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25537.
    PubMed     Abstract available


  475. CAO C, Wei Q, Tang X, Jia Y, et al
    PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: A substudy of a randomized phase III trial.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25601.
    PubMed     Abstract available


  476. TANDON S, Gairola M, Ahlawat P, Karimi AM, et al
    Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25586.
    PubMed     Abstract available


  477. FATTOUH M, Chang GY, Ow TJ, Shifteh K, et al
    Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25420.
    PubMed     Abstract available


  478. DI MAIO P, Iocca O, De Virgilio A, Ferreli F, et al
    Role of palatine tonsillectomy in the diagnostic workup of head and neck squamous cell carcinoma of unknown primary origin: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 21. doi: 10.1002/hed.25522.
    PubMed     Abstract available


  479. KWON DI, Miles BA
    Hypopharyngeal carcinoma: Do you know your guidelines?
    Head Neck. 2018 Dec 20. doi: 10.1002/hed.24752.
    PubMed     Abstract available


  480. VAN DER GEER SJ, van Rijn PV, Kamstra JI, Langendijk JA, et al
    Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25369.
    PubMed     Abstract available


  481. WANG L, Han S, Zhu J, Wang X, et al
    Proton versus photon radiation-induced cell death in head and neck cancer cells.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25357.
    PubMed     Abstract available


  482. KABARRITI R, Baliga S, Ohri N, Guha C, et al
    Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25476.
    PubMed     Abstract available


  483. IBRAHIM MY, Nunez MI, Harun N, Lee JJ, et al
    PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25350.
    PubMed     Abstract available


  484. WANG K, Moon DH, Amdur RJ, Dagan R, et al
    Shoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trials.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25535.
    PubMed     Abstract available


  485. EGYUD M, Sridhar P, Devaiah A, Yamada E, et al
    Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25563.
    PubMed     Abstract available


  486. PLASCHKE CC, Johannesen HH, Hansen RH, Hendel HW, et al
    The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25454.
    PubMed     Abstract available


  487. SLAVIK M, Shatokhina T, Sana J, Ahmad P, et al
    Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25533.
    PubMed     Abstract available


  488. KUBOKI A, Kanaya H, Nakayama T, Konno W, et al
    Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25565.
    PubMed     Abstract available


  489. LEE YA, Li S, Chen Y, Li Q, et al
    Tobacco smoking, alcohol drinking, betel quid chewing, and the risk of head and neck cancer in an East Asian population.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25383.
    PubMed     Abstract available


  490. WANG Y, Xie D, Wang Z, Zhang X, et al
    Kinetics of indocyanine green: Optimizing tumor to normal tissue fluorescence in image-guided oral cancer surgery applications.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25541.
    PubMed     Abstract available


  491. ODENTHAL J, Friedl P, Takes RP
    Compatibility of CO2 laser surgery and fluorescence detection in head and neck cancer cells.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25547.
    PubMed     Abstract available


  492. KARABULUT B
    AHNS series: Do you know our guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25491.
    PubMed    


  493. PAGEDAR NA, Davis AB, Sperry SM, Charlton ME, et al
    Population analysis of socioeconomic status and otolaryngologist distribution on head and neck cancer outcomes.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25521.
    PubMed     Abstract available


  494. PAKKANEN PP, Aaltonen LM, Sorsa TA, Tervahartiala TI, et al
    Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25459.
    PubMed     Abstract available


  495. RUUSKANEN M, Irjala H, Minn H, Vahlberg T, et al
    Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25450.
    PubMed     Abstract available


  496. ARRESE LC, Schieve HJ, Graham JM, Stephens JA, et al
    Relationship between oral intake, patient perceived swallowing impairment, and objective videofluoroscopic measures of swallowing in patients with head and neck cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25542.
    PubMed     Abstract available


  497. GUEZENNEC C, Robin P, Orlhac F, Bourhis D, et al
    Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25433.
    PubMed     Abstract available


  498. SCHIMANSKY S, Lang S, Beynon R, Penfold C, et al
    Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25543.
    PubMed     Abstract available


  499. ZHU Y, Liu H, Xie N, Liu X, et al
    Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25462.
    PubMed     Abstract available


  500. TAMAKI A
    HED-17-0417-AHNS series: Do you know your guidelines? A review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25448.
    PubMed    


  501. GAO W, Wong TS, Lv KX, Zhang MJ, et al
    Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25544.
    PubMed     Abstract available


  502. TUMATI V, Hoang L, Sumer BD, Truelson JM, et al
    Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancer.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25457.
    PubMed     Abstract available


  503. SHAHID N, Iqbal A, Siddiqui AJ, Shoaib M, et al
    Plasma metabolite profiling and chemometric analyses of tobacco snuff dippers and patients with oral cancer: Relationship between metabolic signatures.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25511.
    PubMed     Abstract available


  504. RODNER E, Bocklitz T, von Eggeling F, Ernst G, et al
    Fully convolutional networks in multimodal nonlinear microscopy images for automated detection of head and neck carcinoma: A pilot study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25489.
    PubMed     Abstract available


  505. KIM TH, Lee IJ, Kim JH, Lee CG, et al
    High-dose versus standard-dose radiation therapy for cervical esophageal cancer: A retrospective single-institution study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25483.
    PubMed     Abstract available


  506. QUATRE R, Jacquet T, Atallah I, Tillement O, et al
    Evaluation of the theranostic properties of gadolinium-based nanoparticles for head and neck cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25460.
    PubMed     Abstract available


  507. PANTVAIDYA G, Sivasanker M, Ranganathan P, Pai P, et al
    Prospective cross-sectional study assessing prevalence and factors affecting trismus after multimodal treatment for oral cancers.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25464.
    PubMed     Abstract available


  508. LADANYI A, Kapuvari B, Papp E, Toth E, et al
    Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25546.
    PubMed     Abstract available


  509. ARROYO-SOLERA I, Pavon MA, Leon X, Lopez M, et al
    Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25437.
    PubMed     Abstract available


  510. MIYAMARU S, Minoda R, Kodama N
    Long-term changes in vocal function after supracricoid partial laryngectomy with cricohyoidoepiglottopexy for laryngeal cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25487.
    PubMed     Abstract available


  511. LUMLEY CJ, Kaffenberger TM, Desale S, Tefera E, et al
    Post-diagnosis aspirin use and survival in veterans with head and neck cancer.
    Head Neck. 2018 Dec 11. doi: 10.1002/hed.25518.
    PubMed     Abstract available


  512. FANG FM, Huang TL, Lin YH, Chien CY, et al
    Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25551.
    PubMed     Abstract available


  513. KUWABARA H, Toriihara A, Yuasa-Nakagawa K, Toda K, et al
    Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25490.
    PubMed     Abstract available


  514. YANG CY, Lin CK, Hsieh CC, Tsao CH, et al
    Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25554.
    PubMed     Abstract available


  515. LEE JH, Chun YS, Chung YS
    Extent of lateral neck dissection for papillary thyroid microcarcinomas.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25570.
    PubMed     Abstract available


  516. RYU HJ, Kim EK, Cho BC, Yoon SO, et al
    Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25507.
    PubMed     Abstract available


  517. MCSPADDEN R, Zender C, Eskander A
    AHNS series: Do you know your guidelines? Guideline recommendations for recurrent and persistent head and neck cancer after primary treatment.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25443.
    PubMed     Abstract available


  518. CHOI JB, Lee SG, Kim MJ, Kim TH, et al
    Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25356.
    PubMed     Abstract available


  519. OKAZAKI E, Kawabe J, Oishi M, Hosono M, et al
    Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25429.
    PubMed     Abstract available


  520. HUTCHESON KA, Nurgalieva Z, Zhao H, Gunn GB, et al
    Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25412.
    PubMed     Abstract available


  521. ROTMAN A, Kerr SJ, Giddings CEB
    Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25561.
    PubMed     Abstract available


  522. DRIESSEN CML, Leijendeckers J, Snik A, van der Graaf WTA, et al
    Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25434.
    PubMed     Abstract available


  523. VILASECA I, Nogues-Sabate A, Aviles-Jurado FX, Berenguer J, et al
    Factors of local recurrence and organ preservation with transoral laser microsurgery in laryngeal carcinomas; CHAID decision-tree analysis.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25422.
    PubMed     Abstract available


  524. VON DER GRUN J, Kohn J, Loutfi-Krauss B, Blanck O, et al
    Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2max ) of >180 Gy for patients with recurrent head and neck cancer.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25428.
    PubMed     Abstract available


    November 2018
  525. PAGEDAR NA, Fowlkes JW, Sheffield AM
    Operative technique: Lateral neck dissection.
    Head Neck. 2018 Nov 26. doi: 10.1002/hed.25348.
    PubMed    


  526. WONG ET, Dmytriw AA, Yu E, Waldron J, et al
    (18) F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.
    Head Neck. 2018 Nov 20. doi: 10.1002/hed.25513.
    PubMed     Abstract available


  527. BOSSI P, Miceli R, Benasso M, Corvo R, et al
    Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials.
    Head Neck. 2018 Nov 17. doi: 10.1002/hed.25389.
    PubMed     Abstract available


  528. PARK JC, Gourin CG, Kiess AP, Mehra R, et al
    Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States.
    Head Neck. 2018 Nov 13. doi: 10.1002/hed.25333.
    PubMed     Abstract available


  529. TRUONG AT, Truong DT, Rahlfs TF
    TRS score: A proposed mnemonic for airway assessment and management in patients with head and neck cancers.
    Head Neck. 2018 Nov 2. doi: 10.1002/hed.25502.
    PubMed    


    October 2018
  530. ANSCHUETZ L, Visini M, Shelan M, Elicin O, et al
    Risk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservation.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25373.
    PubMed     Abstract available


  531. LEON X, Pardo L, Sansa A, Fernandez A, et al
    Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25390.
    PubMed     Abstract available


  532. ZHANG N, Fielding R, Soong I, Chan KK, et al
    Illness perceptions as predictors of psychological distress among head and neck cancer survivors: a longitudinal study.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25343.
    PubMed     Abstract available


  533. KILIC S, Kilic SS, Hsueh WD, Eloy JA, et al
    Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25360.
    PubMed     Abstract available


  534. SON HJ, Kim JK, Jung YD, Jang GH, et al
    Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25354.
    PubMed     Abstract available


  535. KOGASHIWA Y, Inoue H, Kuba K, Araki R, et al
    Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25353.
    PubMed     Abstract available


  536. HAMILTON SN, Tran E, Berthelet E, Wu J, et al
    Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
    Head Neck. 2018 Oct 8. doi: 10.1002/hed.25352.
    PubMed     Abstract available


    September 2018
  537. SCRIMGER RA, Seikaly H, Vos LJ, Harris J, et al
    Combination of submandibular salivary gland transfer and intensity-modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck cancer.
    Head Neck. 2018 Sep 3. doi: 10.1002/hed.25339.
    PubMed     Abstract available


    August 2018
  538. DOMINGUES CSDC, Serambeque BP, Laranjo Candido MS, Marto CMM, et al
    Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer.
    Head Neck. 2018 Aug 18. doi: 10.1002/hed.25381.
    PubMed     Abstract available


  539. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25366.
    PubMed     Abstract available


  540. KARATAS OF
    Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25361.
    PubMed     Abstract available


    July 2018
  541. HONG YT, Hong KH
    Identification of lymphatic channels in the tracheoesophageal groove during central neck dissection for thyroid cancer.
    Head Neck. 2018 Jul 26. doi: 10.1002/hed.25125.
    PubMed     Abstract available


    June 2018
  542. MARIONI G, Cappellesso R, Ottaviano G, Fasanaro E, et al
    Nuclear nonmetastatic protein 23-H1 expression and epithelial-mesenchymal transition in laryngeal carcinoma: A pilot investigation.
    Head Neck. 2018 Jun 28. doi: 10.1002/hed.25188.
    PubMed     Abstract available


  543. LEBO NL, Griffiths R, Hall S, Dimitroulakos J, et al
    Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.
    Head Neck. 2018 Jun 22. doi: 10.1002/hed.25152.
    PubMed     Abstract available


  544. OOFT ML, van Ipenburg J, van de Loo RJM, de Jong R, et al
    Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
    Head Neck. 2018 Jun 21. doi: 10.1002/hed.25195.
    PubMed     Abstract available


    May 2018
  545. THAM T, Bardash Y, Herman SW, Costantino PD, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 May 14. doi: 10.1002/hed.25324.
    PubMed     Abstract available


  546. WU JS, Tsai YC, Jian JJ, Chen HH, et al
    Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25205.
    PubMed     Abstract available


  547. LANDEEN KC, Spanos WC, Gromer L
    Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25119.
    PubMed     Abstract available


  548. ANDERSON NJ, Jackson JE, Smith JG, Wada M, et al
    Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25316.
    PubMed     Abstract available


  549. TRIVEDI NP
    Oral cancer involving masticator space (T4b): Review of literature and future directions.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25211.
    PubMed     Abstract available


  550. SUCCO G, Crosetti E, Bertolin A, Piazza C, et al
    Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of different pathologic tumor subcategories.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25176.
    PubMed     Abstract available


  551. ALAHMAD YM, Aljaber M, Saleh AI, Yalcin HC, et al
    Effect of cell-phone radiofrequency on angiogenesis and cell invasion in human head and neck cancer cells.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25210.
    PubMed     Abstract available


  552. SONG JSA, Moolman N, Burrell S, Rajaraman M, et al
    Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25204.
    PubMed     Abstract available


  553. MULCAHY CF, Mohamed ASR, Kanwar A, Hutcheson KA, et al
    Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25200.
    PubMed     Abstract available


  554. ONO T, Azuma K, Kawahara A, Sasada T, et al
    Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25189.
    PubMed     Abstract available


    April 2018
  555. NAIR D, Mair M, Singhvi H, Mishra A, et al
    Perineural invasion: Independent prognostic factor in oral cancer that warrants adjuvant treatment.
    Head Neck. 2018 Apr 29. doi: 10.1002/hed.25170.
    PubMed     Abstract available


  556. HO JC, Phan J
    Reirradiation of head and neck cancer using modern highly conformal techniques.
    Head Neck. 2018 Apr 23. doi: 10.1002/hed.25180.
    PubMed     Abstract available


  557. BERNSTEIN LJ, Pond GR, Gan HK, Tirona K, et al
    Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
    Head Neck. 2018 Apr 17. doi: 10.1002/hed.25198.
    PubMed     Abstract available


  558. FAN CY, Jen YM, Su YC, Chao HL, et al
    Association between nasopharyngeal carcinoma and risk of optic neuropathy: A population-based cohort study.
    Head Neck. 2018 Apr 16. doi: 10.1002/hed.25177.
    PubMed     Abstract available


    March 2018
  559. SHINGLER E, Robles LA, Perry R, Penfold C, et al
    Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia.
    Head Neck. 2018 Mar 30. doi: 10.1002/hed.25138.
    PubMed     Abstract available


  560. HAQUE SU, Niu L, Kuhnell D, Hendershot J, et al
    Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 25. doi: 10.1002/hed.25136.
    PubMed     Abstract available


  561. HEGDE JV, Demanes DJ, Veruttipong D, Chin RK, et al
    Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25137.
    PubMed     Abstract available


  562. KIM HK, Lee I, Lee J, Chang HS, et al
    BRAF(wild) papillary thyroid carcinoma has two distinct mRNA expression patterns with different clinical behaviors.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25151.
    PubMed     Abstract available


  563. RHOTEN BA, Murphy BA, Dietrich MS, Ridner SH, et al
    Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25129.
    PubMed     Abstract available


  564. LUCIONI M, Lionello M, Salis G, Bertolin A, et al
    Bocca's hemipharyngo-total laryngectomy for hypopharyngeal carcinoma to avoid reconstruction with a pedicled flap.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25124.
    PubMed     Abstract available


  565. CONDELLO V, Macerola E, Ugolini C, De Napoli L, et al
    Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25155.
    PubMed     Abstract available


  566. MCEWEN SE, Dunphy C, Rios JN, Davis AM, et al
    Evaluation of a rehabilitation planning consult for survivors of head and neck cancer.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25113.
    PubMed     Abstract available


  567. PAYNE K, Spruce R, Beggs A, Sharma N, et al
    Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25140.
    PubMed     Abstract available


  568. WANG CI, Yu CJ, Huang Y, Yi JS, et al
    Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1beta-induced matrix metalloproteinase expression in oral cancer.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25145.
    PubMed     Abstract available


  569. KIM H, Vargo JA, Beriwal S, Clump DA, et al
    Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25142.
    PubMed     Abstract available


  570. SUZUKI S, Yasunaga H, Matsui H, Fushimi K, et al
    Postoperative mechanical bowel obstruction after pharyngolaryngectomy for hypopharyngeal cancer: Retrospective analysis using a Japanese inpatient database.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25139.
    PubMed     Abstract available


  571. YU F, Lu Y, Petersson F, Wang DY, et al
    Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25131.
    PubMed     Abstract available


  572. DAHER T, Tur MK, Brobeil A, Etschmann B, et al
    Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25041.
    PubMed     Abstract available


  573. WANG X, Li Y, Gao Y, Ouyang D, et al
    Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy predictors and prognostic factors.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25130.
    PubMed     Abstract available


  574. MIZUSHIMA T, Ohnishi S, Shimizu Y, Hatanaka Y, et al
    Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25126.
    PubMed     Abstract available


  575. VUONG HG, Odate T, Duong UNP, Mochizuki K, et al
    Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25123.
    PubMed     Abstract available


  576. LU J, Chen XM, Huang HR, Zhao FP, et al
    Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 1. doi: 10.1002/hed.25104.
    PubMed     Abstract available


    February 2018
  577. PENFOLD CM, Thomas SJ, Waylen A, Ness AR, et al
    Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from head and neck 5000.
    Head Neck. 2018 Feb 27. doi: 10.1002/hed.25116.
    PubMed     Abstract available


  578. HAMSTRA DA, Lee KC, Eisbruch A, Sunkara P, et al
    Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer.
    Head Neck. 2018 Feb 23. doi: 10.1002/hed.25115.
    PubMed     Abstract available


  579. DANILOVIC DLS, de Mello ES, Frazzato EST, Wakamatsu A, et al
    Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
    Head Neck. 2018 Feb 22. doi: 10.1002/hed.25105.
    PubMed     Abstract available


  580. MORISADA M, Chamberlin M, Allen C
    Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.
    Head Neck. 2018 Feb 20. doi: 10.1002/hed.25101.
    PubMed     Abstract available


  581. OSBORN VW, Givi B, Rineer J, Roden D, et al
    Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25103.
    PubMed     Abstract available


  582. CHAN SL, Ng LS, Goh X, Siow CH, et al
    Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25112.
    PubMed     Abstract available


  583. GINGERICH MA, Smith JD, Michmerhuizen NL, Ludwig M, et al
    Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.
    Head Neck. 2018 Feb 10. doi: 10.1002/hed.25057.
    PubMed     Abstract available


  584. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25100.
    PubMed     Abstract available


  585. KIRKE DN, Qureshi MM, Kamran SC, Ezzat W, et al
    Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25087.
    PubMed     Abstract available


  586. MURTHY SP, Balasubramanian D, Subramaniam N, Nair G, et al
    Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25099.
    PubMed     Abstract available


  587. HALL SF, Griffiths RJ
    Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study.
    Head Neck. 2018 Feb 7. doi: 10.1002/hed.25073.
    PubMed     Abstract available


  588. BACK LJJ, Aro K, Tapiovaara L, Vikatmaa P, et al
    Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis.
    Head Neck. 2018 Feb 5. doi: 10.1002/hed.25093.
    PubMed     Abstract available


  589. GUTTMANN DM, Kobie J, Grover S, Lin A, et al
    National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25091.
    PubMed     Abstract available


  590. TALMI YP, Takes RP, Alon EE, Nixon IJ, et al
    Prognostic value of lymph node ratio in head and neck squamous cell carcinoma.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25080.
    PubMed     Abstract available


  591. LIN PJ, Twu CW, Liu YC, Lin TY, et al
    Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25084.
    PubMed     Abstract available


  592. TIRELLI G, Bergamini PR, Scardoni A, Gatto A, et al
    Intraoperative monitoring of marginal mandibular nerve during neck dissection.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25078.
    PubMed     Abstract available


    January 2018
  593. VALLS-MATEUS M, Nogues-Sabate A, Blanch JL, Bernal-Sprekelsen M, et al
    Narrow band imaging for head and neck malignancies: Lessons learned from mistakes.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25088.
    PubMed     Abstract available


  594. NAKAYAMA M, Gosho M, Hirose Y, Nishimura B, et al
    Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25085.
    PubMed     Abstract available


  595. ZENGA J, Pipkorn P, Graboyes EM, Martin EJ, et al
    Oncologic outcomes of extended neck dissections in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2018 Jan 29. doi: 10.1002/hed.25060.
    PubMed     Abstract available


  596. AEBERHARD C, Mayer C, Meyer S, Mueller SA, et al
    Effect of preoperative immunonutrition on postoperative short-term outcomes of patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 24. doi: 10.1002/hed.25072.
    PubMed     Abstract available


  597. VASAN K, Low TH, Gupta R, Ashford B, et al
    Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25066.
    PubMed     Abstract available


  598. LAM JKS, Sundaresan P, Gebski V, Veness MJ, et al
    Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25069.
    PubMed     Abstract available


  599. BAUMEISTER P, Baumuller K, Harreus U, Reiter M, et al
    Evaluation of margins in head and neck squamous cell carcinoma from the surgeon's perspective.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25061.
    PubMed     Abstract available


  600. MASCARELLA MA, Mannard E, Daniela Silva Wurzba S, Zeitouni A, et al
    Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25075.
    PubMed     Abstract available


  601. ESKANDER A, Strigenz D, Seim N, Ozer E, et al
    Submental artery island flap with simultaneous level I neck dissection.
    Head Neck. 2018 Jan 13. doi: 10.1002/hed.25044.
    PubMed     Abstract available


  602. REN Y, Deschler DG, Sajed D, Durand ML, et al
    Case of late-onset, relapsing surgical site infection related to a venous coupler placed during free flap reconstruction for major head and neck cancer.
    Head Neck. 2018 Jan 12. doi: 10.1002/hed.25043.
    PubMed     Abstract available


  603. OKER N, Verillaud B, Wassef M, Froelich S, et al
    Ethmoidal adenocarcinoma treated by exclusive endoscopic approach: Focus on learning curve and modification of management.
    Head Neck. 2018;40:126-136.
    PubMed     Abstract available


  604. LEE DJ, Chin CJ, Hong CJ, Perera S, et al
    Outpatient versus inpatient thyroidectomy: A systematic review and meta-analysis.
    Head Neck. 2018;40:192-202.
    PubMed     Abstract available


  605. KNIGGE MA, Thibeault SL
    Swallowing outcomes after cricopharyngeal myotomy: A systematic review.
    Head Neck. 2018;40:203-212.
    PubMed     Abstract available


  606. MATTAVELLI D, Schreiber A, Villaret AB, Accorona R, et al
    Complications and donor site morbidity of 3-layer reconstruction with iliotibial tract of the anterior skull base: Retrospective analysis of 186 patients.
    Head Neck. 2018;40:63-69.
    PubMed     Abstract available


  607. LANSU J, Klop WM, Heemsbergen W, Navran A, et al
    Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy.
    Head Neck. 2018;40:86-93.
    PubMed     Abstract available


    December 2017
  608. AVINCSAL MO, Shinomiya H, Teshima M, Kubo M, et al
    Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer.
    Head Neck. 2017 Dec 29. doi: 10.1002/hed.25050.
    PubMed     Abstract available


  609. DEJACO D, Steinbichler T, Schartinger VH, Fischer N, et al
    Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
    Head Neck. 2017 Dec 22. doi: 10.1002/hed.25040.
    PubMed     Abstract available


  610. SON HJ, Roh JL, Choi SH, Nam SY, et al
    Nutritional and hematologic markers as predictors of risk of surgical site infection in patients with head and neck cancer undergoing major oncologic surgery.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25031.
    PubMed     Abstract available


  611. SANABRIA A, Kowalski LP, Shah JP, Nixon IJ, et al
    Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25029.
    PubMed     Abstract available


    November 2017
  612. FULCHER CD, Haigentz M Jr, Ow TJ
    AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
    Head Neck. 2017 Nov 24. doi: 10.1002/hed.25025.
    PubMed     Abstract available


  613. ESKANDER A, Ghanem T, Agrawal A
    AHNS Series: Do you know your guidelines? Guideline recommendations for head and neck cancer of unknown primary site.
    Head Neck. 2017 Nov 21. doi: 10.1002/hed.25026.
    PubMed     Abstract available


  614. CAO C, Hu Q, Chen X
    Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25016.
    PubMed     Abstract available


  615. WONG DJY, Donaldson C, Lai LT, Coleman A, et al
    Safety and effectiveness of endovascular embolization or stent-graft reconstruction for treatment of acute carotid blowout syndrome in patients with head and neck cancer: Case series and systematic review of observational studies.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25018.
    PubMed     Abstract available


  616. LECHELT LA, Rieger JM, Cowan K, Debenham BJ, et al
    Top 10 research priorities in head and neck cancer: Results of an Alberta priority setting partnership of patients, caregivers, family members, and clinicians.
    Head Neck. 2017 Nov 17. doi: 10.1002/hed.24998.
    PubMed     Abstract available


  617. MAYS AC, Bartels HG, Wistermayer PR, Rohlfing ML, et al
    Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population.
    Head Neck. 2017 Nov 13. doi: 10.1002/hed.24992.
    PubMed     Abstract available


  618. LEONG YH, Soon YY, Lee KM, Wong LC, et al
    Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24993.
    PubMed     Abstract available


  619. DAVIDI ES, Dreifuss T, Motiei M, Shai E, et al
    Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24935.
    PubMed     Abstract available


  620. KAMSTRA JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU, et al
    Exercise therapy for trismus secondary to head and neck cancer: A systematic review.
    Head Neck. 2017;39:2352-2362.
    PubMed     Abstract available


    October 2017
  621. CHAN JYW, Wong STS, Wei WI
    Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.
    Head Neck. 2017 Oct 30. doi: 10.1002/hed.24976.
    PubMed     Abstract available


  622. TAMAKI A, Miles BA, Lango M, Kowalski L, et al
    AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24862.
    PubMed     Abstract available


  623. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24986.
    PubMed     Abstract available


  624. PENG S, Wu C, Sun W, Liu D, et al
    Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell.
    Head Neck. 2017 Oct 12. doi: 10.1002/hed.24982.
    PubMed     Abstract available


  625. HUANG WB, Wong STS, Chan JYW
    Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2017 Oct 9. doi: 10.1002/hed.24973.
    PubMed     Abstract available


  626. LIU JC
    Head and Neck Cancer, Multimodality Management, 2nd ed, Editor: Jacques Bernier Jeffrey C. Liu Springer, Switzerland, 2016, USD $329, 878 pages.
    Head Neck. 2017 Oct 5. doi: 10.1002/hed.24920.
    PubMed    


    September 2017
  627. FAN CY, Chao HL, Lin CS, Huang WY, et al
    Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24961.
    PubMed     Abstract available


  628. LECHIEN JR, Nassri A, Kindt N, Brown DN, et al
    Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24939.
    PubMed     Abstract available


  629. ONG HS, Gokavarapu S, Al-Qamachi L, Yin MY, et al
    Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24914.
    PubMed     Abstract available


  630. BURNS CL, Kularatna S, Ward EC, Hill AJ, et al
    Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24916.
    PubMed     Abstract available


  631. LOMBARDI D, Paderno A, Giordano D, Barbieri D, et al
    Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24936.
    PubMed     Abstract available


  632. AVILES-JURADO FX, Flores JC, Guma J, Ceperuelo-Mallafre V, et al
    Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24919.
    PubMed     Abstract available


  633. QIU J, Lv B, Fu M, Wang X, et al
    18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24925.
    PubMed     Abstract available


  634. LIU H, Zhang Y, Zhang T, Li F, et al
    Correlation between the pathology and clinical presentations in patients with adenoid cystic carcinoma of the external auditory canal.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24915.
    PubMed     Abstract available


  635. KAWAKITA D, Lee YA, Li Q, Chen Y, et al
    Impact of oral hygiene on head and neck cancer risk in a Chinese population.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24929.
    PubMed     Abstract available


  636. LUCIONI M, D'Ascanio L, De Nardi E, Lionello M, et al
    Management of paratracheal lymph nodes in laryngeal cancer with subglottic involvement.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24905.
    PubMed     Abstract available


  637. CHENG SJ, Chang CF, Ko HH, Lee JJ, et al
    Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24958.
    PubMed     Abstract available


  638. ITO M, Kodaira T, Tachibana H, Tomita N, et al
    Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24909.
    PubMed     Abstract available


  639. ZHANG H, Kim S, Chen Z, Nannapaneni S, et al
    Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24911.
    PubMed     Abstract available


  640. DA FONSECA FL, Yamanaka PK, Mazoti L, Arakawa-Sugueno L, et al
    Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24895.
    PubMed     Abstract available


    May 2017
  641. ZHANG D, Li F, Wu CW, Liu X, et al
    Percutaneous probe stimulation for intraoperative neuromonitoring in total endoscopic thyroidectomy: A preliminary experience.
    Head Neck. 2017;39:1001-1007.
    PubMed     Abstract available


  642. LOPEZ F, Triantafyllou A, Snyderman CH, Hunt JL, et al
    Nasal juvenile angiofibroma: Current perspectives with emphasis on management.
    Head Neck. 2017;39:1033-1045.
    PubMed     Abstract available


  643. WELLER MA, Ward MC, Berriochoa C, Reddy CA, et al
    Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2017;39:940-946.
    PubMed     Abstract available


  644. MORISOD B, Venara-Vulpe II, Alzuphar S, Monnier Y, et al
    Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
    Head Neck. 2017;39:965-973.
    PubMed     Abstract available


  645. LANSAAT L, van den Boer C, Muller SH, van der Noort V, et al
    Ex vivo humidifying capacity and patient acceptability of stoma cloths in laryngectomized individuals.
    Head Neck. 2017;39:921-931.
    PubMed     Abstract available


    April 2017
  646. GARCIA-OLMO DC, Contreras JD, Picazo MG, Lopez-Torres J, et al
    Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
    Head Neck. 2017;39:647-655.
    PubMed     Abstract available


  647. VAN LOON Y, Stiggelbout AM, Hakkesteegt MM, Langeveld TP, et al
    Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma.
    Head Neck. 2017;39:779-785.
    PubMed     Abstract available


  648. DUEK I, Amit M, Sviri GE, Gil Z, et al
    Combined endoscopic transcervical-transoral robotic approach for resection of parapharyngeal space tumors.
    Head Neck. 2017;39:786-790.
    PubMed     Abstract available


  649. ZHOU L, Luo W
    Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.
    Head Neck. 2017;39:656-661.
    PubMed     Abstract available


  650. TURRI-ZANONI M, Salzano G, Lambertoni A, Giovannardi M, et al
    Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Head Neck. 2017;39:730-736.
    PubMed     Abstract available


  651. ALMADORI G, Lauriola L, Coli A, Bussu F, et al
    Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
    Head Neck. 2017;39:684-693.
    PubMed     Abstract available


  652. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Lepera D, et al
    Transnasal endoscopic partial maxillectomy: Operative nuances and proposal for a comprehensive classification system based on 1378 cases.
    Head Neck. 2017;39:754-766.
    PubMed     Abstract available


    March 2017
  653. SIDDIQUI F, Smith RV, Yom SS, Beitler JJ, et al
    ACR appropriateness criteria((R)) nasal cavity and paranasal sinus cancers.
    Head Neck. 2017;39:407-418.
    PubMed     Abstract available


  654. IWAKI S, Maeda T, Saito M, Otsuki N, et al
    Role of immediate recurrent laryngeal nerve reconstruction in surgery for thyroid cancers with fixed vocal cords.
    Head Neck. 2017;39:427-431.
    PubMed     Abstract available


  655. NISHIO N, Fujii M, Hayashi Y, Hiramatsu M, et al
    Preoperative surgical simulation and validation of the line of resection in anterolateral craniofacial resection of advanced sinonasal sinus carcinoma.
    Head Neck. 2017;39:512-519.
    PubMed     Abstract available


  656. LOMBARDI D, Mattavelli D, Redaelli De Zinis LO, Accorona R, et al
    Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease.
    Head Neck. 2017;39:E45-E50.
    PubMed     Abstract available


  657. SIVARS L, Landin D, Haeggblom L, Tertipis N, et al
    Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Head Neck. 2017;39:419-426.
    PubMed     Abstract available


  658. MATTHEIS S, Hasskamp P, Holtmann L, Schafer C, et al
    Flex Robotic System in transoral robotic surgery: The first 40 patients.
    Head Neck. 2017;39:471-475.
    PubMed     Abstract available


  659. YU Y, Mabray M, Silveira W, Shen PY, et al
    Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Head Neck. 2017;39:432-438.
    PubMed     Abstract available


    February 2017
  660. GOOI Z, Richmon J, Agrawal N, Blair E, et al
    AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.
    Head Neck. 2017;39:201-205.
    PubMed     Abstract available


  661. FRISCH T
    Versatility of the facial artery myomucosal island flap in neopharyngeal reconstruction.
    Head Neck. 2017;39:E29-E33.
    PubMed     Abstract available


  662. MCDOWELL LJ, Jacobson MC, Levin W
    High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
    Head Neck. 2017;39:E23-E28.
    PubMed     Abstract available


  663. MEHTA V, Flores JM, Thompson RW, Nathan CA, et al
    Primary payer status, individual patient characteristics, and hospital-level factors affecting length of stay and total cost of hospitalization in total laryngectomy.
    Head Neck. 2017;39:311-319.
    PubMed     Abstract available


  664. GAVRIEL H, Eviatar E, Abu Eta R
    Hyperbaric oxygen therapy for maxillary bone radiation-induced injury: A 15-year single-center experience.
    Head Neck. 2017;39:275-278.
    PubMed     Abstract available


  665. WEAVER AN, Cooper TS, Wei S, Carroll WR, et al
    DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery.
    Head Neck. 2017;39:206-214.
    PubMed     Abstract available


    January 2017
  666. HOFSTEDE TM, Jacob RF, Montgomery P, Wesley P, et al
    Surgical preparation of nasal defects to enhance the implant-retained facial prostheses: A case report.
    Head Neck. 2017;39:E4-E11.
    PubMed     Abstract available


  667. ALLENSWORTH JJ, O'Dell KD, Schindler JS
    Bilateral vocal fold paralysis and dysphagia secondary to diffuse idiopathic skeletal hyperostosis.
    Head Neck. 2017;39:E1-E3.
    PubMed     Abstract available


  668. BEECH NM, Porceddu S, Batstone MD
    Radiotherapy-associated dental extractions and osteoradionecrosis.
    Head Neck. 2017;39:128-132.
    PubMed     Abstract available


  669. ANSARIN M, Cattaneo A, De Benedetto L, Zorzi S, et al
    Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery.
    Head Neck. 2017;39:71-81.
    PubMed     Abstract available


  670. RACKLEY TP, Namelo WC, Palaniappan N, Cole N, et al
    Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil.
    Head Neck. 2017;39:17-23.
    PubMed     Abstract available


  671. BAUMEISTER P, Rauch J, Jacobi C, Kisser U, et al
    Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
    Head Neck. 2017;39:7-16.
    PubMed     Abstract available


    April 2016
  672. SABA NF, Salama JK, Beitler JJ, Busse PM, et al
    ACR Appropriateness criteria(R) for nasopharyngeal carcinoma.
    Head Neck. 2016 Apr 30. doi: 10.1002/hed.24423.
    PubMed     Abstract available


  673. ROSKO AJ, Spector ME, Griffin GR, Vainshtein JM, et al
    Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer.
    Head Neck. 2016 Apr 15. doi: 10.1002/hed.24348.
    PubMed     Abstract available


  674. OMURA G, Ando M, Saito Y, Kobayashi K, et al
    Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer.
    Head Neck. 2016 Apr 9. doi: 10.1002/hed.24176.
    PubMed     Abstract available


  675. CHOI YS, Park SG, Song EK, Cho SH, et al
    Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Head Neck. 2016 Apr 4. doi: 10.1002/hed.24438.
    PubMed     Abstract available


    March 2016
  676. HARRIS BN, Bhuskute AA, Rao S, Farwell DG, et al
    Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Head Neck. 2016 Mar 25. doi: 10.1002/hed.24443.
    PubMed     Abstract available


  677. PERETTI G, Piazza C, Penco S, Santori G, et al
    Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
    Head Neck. 2016 Mar 11. doi: 10.1002/hed.24424.
    PubMed     Abstract available


    February 2016
  678. EDSON MA, Garden AS, Takiar V, Glisson BS, et al
    Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy.
    Head Neck. 2016 Feb 27. doi: 10.1002/hed.24387.
    PubMed     Abstract available


  679. XIONG J, Krishnaswamy G, Raynor S, Loh KS, et al
    Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.
    Head Neck. 2016 Feb 18. doi: 10.1002/hed.24296.
    PubMed     Abstract available


  680. VENGALIL S, Giuliani ME, Huang SH, McNiven A, et al
    Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.
    Head Neck. 2016 Feb 1. doi: 10.1002/hed.24374.
    PubMed     Abstract available


    December 2015
  681. LEWIS GD, Holliday EB, Kocak-Uzel E, Hernandez M, et al
    Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes.
    Head Neck. 2015 Dec 26. doi: 10.1002/hed.24341.
    PubMed     Abstract available


  682. FLORIE M, Baijens L, Kremer B, Kross K, et al
    Relationship between swallow-specific quality of life and fiber-optic endoscopic evaluation of swallowing findings in patients with head and neck cancer.
    Head Neck. 2015 Dec 23. doi: 10.1002/hed.24333.
    PubMed     Abstract available


  683. OUYOUNG LM, Swanson MS, Villegas BC, Damodar D, et al
    ABCLOVE: Voice therapy outcomes for patients with head and neck cancer.
    Head Neck. 2015 Dec 22. doi: 10.1002/hed.24322.
    PubMed     Abstract available


  684. SENGAR M, Chorghe S, Jadhav K, Singh S, et al
    Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine.
    Head Neck. 2015 Dec 15. doi: 10.1002/hed.24297.
    PubMed     Abstract available


    November 2015
  685. DRIESSEN CM, Uijen MJ, van der Graaf WT, van Opstal CC, et al
    Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer.
    Head Neck. 2015 Nov 28. doi: 10.1002/hed.24281.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: